type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size font family time roman align right exhibit style font size margin margin bottom nbsp style line height margin margin bottom border bottom solid nbsp style margin margin bottom font size font family time roman align center license collaboration agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center miragen therapeutic style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center laboratoires servier style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center institut recherches servier style font size margin margin bottom nbsp style line height margin margin bottom border bottom solid nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center license collaboration agreement style margin margin bottom text indent font size font family time roman this license collaboration agreement this agreement made october nbsp effective date between miragen therapeutic corporation organized existing under delaware having principal place business lookout suite boulder miragen first part laboratoires servier corporation organized existing under france having office carnot suresnes cedex france institut recherches servier corporation organized existing under france having office eacute publique suresnes france these entity jointly referred servier second part servier miragen referred this agreement individually party collectively party style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman whereas miragen biotechnology company focused research development pharmaceutical product directed mirna target owns control valuable proprietary technology relating such mirna target product directed thereto style margin margin bottom text indent font size font family time roman whereas servier pharmaceutical company working create develop novel therapy style margin margin bottom text indent font size font family time roman whereas servier been evaluating certain miragen target product under material transfer agreement between party dated january nbsp style margin margin bottom text indent font size font family time roman whereas miragen servier desire establish collaboration research development successful commercialization product directed mirna target treatment cardiovascular disease under term condition forth herein style margin margin bottom text indent font size font family time roman therefore consideration foregoing premise mutual covenant contained herein receipt sufficiency which hereby acknowledged servier miragen hereby agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom text indent font size font family time roman unless context otherwise requires term this agreement with initial letter capitalized shall have meaning forth below meaning designated indicated place throughout this agreement style margin margin bottom text indent font size font family time roman acquiror defined section style margin margin bottom text indent font size font family time roman active ingredient mean clinically active material that provide pharmacological activity pharmaceutical product excluding formulation component such coating stabilizer excipients solvent adjuvant controlled release technology style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman additional target defined section style margin margin bottom text indent font size font family time roman additional third party companion diagnostic license agreement defined section style margin margin bottom text indent font size font family time roman additional third party therapeutic license agreement defined section style margin margin bottom text indent font size font family time roman affiliate mean with respect party person that control controlled under common control with that party purpose this definition control including with correlative meaning term controlled under common control mean actual power either directly indirectly through more intermediary direct cause direction management policy such person whether ownership more than fifty percent nbsp voting stocking such person contract otherwise style margin margin bottom text indent font size font family time roman alliance business development manager defined section style margin margin bottom text indent font size font family time roman alliance manager defined section style margin margin bottom text indent font size font family time roman cardiovascular disease mean disease disorder medical condition relating structural functional abnormality cardiovascular system that impairs normal functioning including disease disorder medical condition that directly involves affect heart vascular system including stroke clarity cardiovascular disease excludes hematological disorder immunological disorder neoplasm neurological disorder metabolic disorder except direct vascular cardiovascular effect metabolic disorder style margin margin bottom text indent font size font family time roman change control mean with respect miragen nbsp sale third party substantially miragen asset business relating subject matter this agreement nbsp merger reorganization consolidation involving miragen third party which voting security miragen outstanding immediately prior thereto cease represent least fifty percent nbsp combined voting power surviving entity immediately after such merger reorganization consolidation nbsp acquisition third party more than fifty percent nbsp voting equity security miragen result single transaction series related transaction change control shall exclude private financing provided that acquisition more than fifty percent nbsp voting equity security miragen result single transaction series related transaction venture fund pharmaceutical company excluded from change control initial public offering miragen security style margin margin bottom text indent font size font family time roman claim mean third party demand claim action proceeding liability whether criminal civil contract tort otherwise loss damage reasonable legal cost other reasonable expense nature style margin margin bottom text indent font size font family time roman combination product defined section nbsp definition sale style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercialization mean activity directed marketing distribution detailing selling licensed product field well importing exporting activity connection therewith activity directed obtaining pricing approval activity directed phase study style margin margin bottom text indent font size font family time roman commercialization plan defined section style margin margin bottom text indent font size font family time roman commercially reasonable effort mean nbsp where applied carrying specific task obligation party under this agreement expending reasonable diligent good faith effort resource accomplish such task obligation such party acting through affiliate sublicensees subcontractor would normally accomplish similar task obligation under similar circumstance nbsp where applied development manufacture commercialization licensed product reasonable diligent good faith effort resource active ongoing program normally used such party product discovered identified internally such party which product similar stage development product life similar market potential similar term profitability without taking into account effect payment miragen pursuant this agreement except extent that such payment cause reasonably expected cause relevant licensed product unprofitable have negative present value based servier usual financial evaluation style margin margin bottom text indent font size font family time roman committee mean jrdc subcommittee established under section nbsp applicable style margin margin bottom text indent font size font family time roman companion diagnostic mean diagnostic product service that specific particular licensed product nbsp identifies whether patient candidate treatment with such licensed product indication field nbsp allows follow efficacy such licensed product nbsp allows define therapeutic objective treatment with such licensed product style margin margin bottom text indent font size font family time roman companion diagnostic contracting party meaning forth section style margin margin bottom text indent font size font family time roman companion diagnostic development cost defined section style margin margin bottom text indent font size font family time roman confidential information party mean proprietary know unpublished patent application other information data financial commercial business operational technical nature such party including information comprising relating concept discovery invention data design formula relation this agreement that nbsp disclosed behalf such party affiliate otherwise made available other party affiliate whether made available orally writing electronic form nbsp learned other party pursuant this agreement style margin margin bottom text indent font size font family time roman confidentiality agreement defined section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman control controlled mean with respect know patent right other intellectual property right that party legal authority right whether ownership license otherwise grant license sublicense access right applicable under such know patent right other intellectual property right other party term condition forth herein each case without breaching term agreement with third party style margin margin bottom text indent font size font family time roman cost good mean with respect particular licensed oligo licensed product style margin margin bottom text indent font size font family time roman such licensed oligo licensed product manufactured third party manufacturer nbsp miragen servier actual third party cost expressed unit manufactured basis manufacturing processing testing filling finishing packaging labeling such licensed oligo licensed product nbsp cost incurred miragen servier manufacturing oversight quality assurance with respect such licensed oligo licensed product style margin margin bottom text indent font size font family time roman such licensed oligo licensed product manufactured miragen servier actual fully burdened cost manufacturing processing testing filling finishing packaging labeling such licensed oligo licensed product including without limitation material direct labor benefit proportionate share indirect manufacturing cost nbsp clarity such fully burdened cost shall calculated nbsp theoretical full capacity basis with reasonable changeover maintenance downtime with percentage allocable cost good representing number unit licensed oligo licensed product produced performed percentage total number unit including those other product that could manufactured such facility during calendar year nbsp accordance with ifrs gaap whichever such manufacturing party throughout organization time question consistently applied with allocation miragen servier calculated accordance with methodology unanimously approved which methodology shall consistent with ifrs gaap applicable based upon similar activity conducted miragen servier disproportionately allocate cost manufacturing licensed oligo licensed product when compared similar cost other manufacturing activity miragen servier cost that identified specific activity supporting product manufacturing such charge central corporate overhead that controllable manufacturing plant shall included determination cost good style margin margin bottom font size font family time roman clarity cost good include margin mark relating inter company supply between party affiliate among such affiliate style margin margin bottom text indent font size font family time roman mean investigational drug application clinical trial application clinical trial exemption similar equivalent application submission approval conduct human clinical investigation filed with submitted regulatory authority conformance with requirement such regulatory authority style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman develop development mean development activity licensed product field beginning with impd enabling toxicology study such licensed product including clinical testing study such licensed product manufacturing development process development toxicology study distribution licensed product clinical trial including placebo comparators research development companion diagnostic after selection relevant selected biomarker pursuant section nbsp connection with clinical trial licensed product well approved licensed product statistical analysis preparation filing prosecution marketing approval application such licensed product well regulatory affair related foregoing development shall include discovery design identification modification derivatization licensed oligos clinical preclinical testing licensed product prior their selection selected licensed product pursuant section nbsp style margin margin bottom text indent font size font family time roman development budget defined section style margin margin bottom text indent font size font family time roman development cost mean actual direct cost expense incurred party affiliate account calculated accordance with ifrs gaap whichever such party throughout organization time question consistently applied that specifically identifiable reasonably consistently allocable development licensed product that directed achieving maintaining regulatory approval licensed product development cost shall include amount without mark that party third party involved such development work internal cost incurred party connection with such development work development cost include following nbsp clinical cost such cost toxicology pharmacokinetics metabolism pharmacological study that incurred after selection selected licensed product pursuant section nbsp nbsp cost formulation development process development test method development delivery system development stability testing nbsp cost phase clinical trial phase clinical trial phase clinical trial licensed product including ethic committee investigator investigator meeting cost clinical research organization service limited following activity monitoring central core laboratory service including bioanalysis medical writing data management statistic analysis analysis nbsp cost good licensed oligos licensed product development activity including manufacture purchase packaging comparators placebo clinical study licensed product well direct cost expense transportation storage disposal drug other supply used such clinical study inventory write offs capacity reservation charge therefor nbsp cost manufacturing process development licensed oligo licensed product including scale validation improvement qualification validation manufacturing site manufacturer nbsp regulatory expense relating development activity purpose obtaining regulatory approval licensed product excluding filing maas nbsp cost developing companion diagnostic after selection relevant selected biomarker nbsp other cost expense that meet criterion forth above development cost shall specifically exclude general corporate administrative overhead each party calculating development cost each party effort shall calculated rate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman development plan defined section nbsp style margin margin bottom text indent font size font family time roman development plan cost mean nbsp development cost incurred party conducting development activity assigned under development plan provided that such cost consistent with development budget exceed relevant amount forth budget more than unless approved writing jrdc nbsp such other cost expressly approved writing jrdc development plan cost style margin margin bottom text indent font size font family time roman disclosing party defined section style margin margin bottom text indent font size font family time roman mean european medicine agency successor entity thereto style margin margin bottom text indent font size font family time roman european union mean european union member state altered from time time style margin margin bottom text indent font size font family time roman executive officer defined section style margin margin bottom text indent font size font family time roman mean united state food drug administration successor entity thereto style margin margin bottom text indent font size font family time roman field mean treatment prevention mitigation cardiovascular disease field include diagnostic application licensed product companion diagnostics used connection with development commercialization licensed product field style margin margin bottom text indent font size font family time roman filing marketing approval application mean acceptance regulatory authority marketing approval application filing review applicable otherwise submission such marketing approval application style margin margin bottom text indent font size font family time roman first commercial sale mean with respect licensed product country jurisdiction territory first sale such licensed product third party other than licensee sublicensee distribution consumption such country jurisdiction after regulatory approval have been obtained such licensed product such country jurisdiction style margin margin bottom text indent font size font family time roman mean equivalent full time individual work twelve nbsp month period according applicable country where individual employed effort shall include work general corporate administrative personnel style margin margin bottom text indent font size font family time roman rate mean initial rate year commencing january nbsp rate shall changed annually calendar year basis reflect year year percentage increase decrease case consumer price index indice prix agrave consommation insee france local equivalent country where individual employed based change from most recent index available effective date most recent index available date calculation such revised rate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman gaap mean united state generally accepted accounting principle consistent applied style margin margin bottom text indent font size font family time roman generic competitor mean with respect particular licensed product country pharmaceutical product that nbsp contains highly similar such licensed product regulated such country biological product identical such licensed product regulated such country small molecule other chemical entity product active ingredient such licensed product nbsp approved such country pursuant abbreviated expedited regulatory approval process other process country where there such abbreviated expedited process governing approval generic pharmaceutical product similar product based nbsp then current standard regulatory approval such country nbsp data generated party pursuant this agreement nbsp sold same country such licensed product third party that licensee sublicensee servier such product such licensed product affiliate servier that purchase such product chain distribution that included servier affiliate such licensee sublicensees style margin margin bottom text indent font size font family time roman government authority mean federal national state provincial local government political subdivision thereof multinational organization authority agency commission entitled exercise administrative executive judicial legislative police regulatory taxing authority power court tribunal department bureau division thereof governmental arbitrator arbitral body style margin margin bottom text indent font size font family time roman ifrs mean international financial reporting standard style margin margin bottom text indent font size font family time roman impd mean investigational medicinal product dossier successor thereto other data package submission regulatory authority part style margin margin bottom text indent font size font family time roman indemnified party defined section style margin margin bottom text indent font size font family time roman indemnifying party defined section style margin margin bottom text indent font size font family time roman initiation mean with respect clinical trial licensed product first dosing first human subject such clinical trial style margin margin bottom text indent font size font family time roman invention shall mean process method composition matter article manufacture discovery finding patentable otherwise that invented result party exercising right carrying obligation under this agreement including right title interest intellectual property right therein style margin margin bottom text indent font size font family time roman joint executive committee defined section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman joint defined section style margin margin bottom text indent font size font family time roman joint know defined section style margin margin bottom text indent font size font family time roman joint patent defined section style margin margin bottom text indent font size font family time roman joint research development committee jrdc defined section nbsp style margin margin bottom text indent font size font family time roman joint steering committee defined section nbsp style margin margin bottom text indent font size font family time roman know mean information material including discovery improvement modification process method protocol formula data invention know trade secret patentable otherwise excluding patent right style margin margin bottom text indent font size font family time roman mean federal state local foreign multinational statute standard ordinance code rule regulation resolution promulgation order government authority license franchise permit similar right granted under foregoing similar provision having force effect style margin margin bottom text indent font size font family time roman licensed oligo mean oligonucleotide identified miragen either prior effective date during course miragen performance research plan each case direct selective modulator target style margin margin bottom text indent font size font family time roman licensed product mean pharmaceutical product containing licensed oligo alone combination with other active ingredient which another licensed oligo shall active ingredient that proprietary miragen that licensed oligo formulation dosage form mode administration style margin margin bottom text indent font size font family time roman marketing authorization application mean application appropriate regulatory authority approval market licensed product excluding pricing approval field particular jurisdiction amendment supplement thereto style margin margin bottom text indent font size font family time roman major indication mean indication field that projected annual peak sale territory least style margin margin bottom text indent font size font family time roman major market country mean nbsp nbsp following country territory servier request time upon miragen consent such consent unreasonably withheld provided that servier provides miragen information reasonably requested miragen regarding basis servier request replace foregoing list major market country style margin margin bottom text indent font size font family time roman miragen acquiror defined section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman miragen companion diagnostic mean patent right know that nbsp controlled miragen affiliate subject section nbsp effective date during term nbsp reasonably necessary useful development manufacture importation sale companion diagnostic miragen companion diagnostic shall include miragen right joint that satisfies notwithstanding foregoing shall exclude nbsp patent right know that satisfy arose from unsponsored work performed miragen unless until servier reimburses miragen such work accordance with section nbsp nbsp patent right know licensed miragen affiliate pursuant license agreement entered into after effective date that additional third party companion diagnostic license style margin margin bottom text indent font size font family time roman miragen indemnitee defined section style margin margin bottom text indent font size font family time roman miragen know mean know included miragen therapeutic miragen companion diagnostic miragen know shall include miragen interest joint know style margin margin bottom text indent font size font family time roman miragen partner defined section style margin margin bottom text indent font size font family time roman miragen partner agreement defined section nbsp style margin margin bottom text indent font size font family time roman miragen patent mean patent right included miragen therapeutic miragen companion diagnostic miragen patent existing effective date forth exhibit miragen patent shall include miragen interest joint patent style margin margin bottom text indent font size font family time roman miragen sole patent defined section style margin margin bottom text indent font size font family time roman miragen therapeutic mean patent right know that nbsp controlled miragen affiliate subject section nbsp effective date during term nbsp reasonably necessary useful development manufacture importation sale licensed oligos licensed product field miragen therapeutic shall include miragen right joint that satisfies notwithstanding foregoing shall exclude nbsp patent right know that satisfy arose from unsponsored work performed miragen unless until servier reimburses miragen such work accordance with section nbsp nbsp patent right know licensed miragen affiliate pursuant license agreement entered into after effective date that additional third party therapeutic license style margin margin bottom text indent font size font family time roman defined recital style margin margin bottom text indent font size font family time roman sale mean case sale benefit servier affiliate sublicensees seller independent unrelated person buyer bona fide length transaction except provided below with respect clinical trial sample gross amount billed invoiced seller with respect licensed product following deduction each case extent actually allowed taken such buyer otherwise recovered reimbursed seller connection with such nbsp licensed product permitted deduction nbsp trade cash promotional quantity discount style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman extent that such amount forth separately such total amount billed invoiced nbsp sale such excise sale value added extent imposed upon paid directly with respect sale price forth separately such total amount billed invoiced excluding national state local based income nbsp sale reimbursed pharmaceutical specialty nbsp freight insurance packing cost other transportation charge extent added sale price forth separately such total amount billed invoiced nbsp amount repaid credit taken reason rejection defect return because retroactive price reduction recall regulation requiring rebate nbsp free good rebate taken paid distributor charge back extent that such amount documented nbsp documented custom duty actually paid seller import into country sale viii nbsp rebate discount sale licensed product given health insurance other type payer given country territory specific agreement claw back type agreement involving licensed product sale shall include consideration received with respect sale other disposition licensed product country part clinical trial necessary obtain regulatory approval such country foregoing element sale calculation shall determined accordance with ifrs successor standard guideline thereto case transfer nbsp licensed product between servier sublicensees affiliate foregoing subsequent sale rental nbsp lease nbsp nbsp other transfer such nbsp licensed product third party sale shall gross invoice contract price charged third party customer that licensed product deduction forth clause nbsp through viii nbsp above style margin margin bottom font size font family time roman event that licensed product consists combination licensed oligo with more other active ingredient combination product sale purpose determining royalty payment shall discussed agreed party taking into account relative value licensed oligo other active ingredient style margin margin bottom text indent font size font family time roman major indication mean indication field that neither orphan indication major indication style margin margin bottom text indent font size font family time roman orphan indication mean indication field that satisfies criterion orphan disease style margin margin bottom text indent font size font family time roman patent right mean patent patent application which purpose this agreement shall deemed include certificate invention application certificate invention including divisionals continuation substitution continuation part examination reissue addition renewal revalidations extension registration pediatric exclusivity period supplemental protection certificate including pediatric extension thereof like such patent patent application foreign equivalent foregoing style margin margin bottom text indent font size font family time roman person mean individual partnership limited liability company firm corporation association trust unincorporated organization other entity style margin margin bottom text indent font size font family time roman pharmacovigilance agreement defined section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman phase clinical trial shall mean human clinical trial licensed product that would satisfy requirement regardless whether such trial referred phase clinical trial development plan style margin margin bottom text indent font size font family time roman phase clinical trial shall mean controlled human clinical trial licensed product that would satisfy requirement regardless whether such trial referred phase clinical trial development plan style margin margin bottom text indent font size font family time roman phase clinical trial shall mean controlled uncontrolled human clinical trial licensed product that would satisfy requirement regardless whether such trial referred phase clinical trial development plan style margin margin bottom text indent font size font family time roman phase cost defined section style margin margin bottom text indent font size font family time roman phase study mean study data collection effort respect licensed product particular indication that initiated after receipt regulatory approval such licensed product such indication style margin margin bottom text indent font size font family time roman phase cost defined section style margin margin bottom text indent font size font family time roman pricing approval mean such governmental approval agreement determination decision establishing price licensed product that charged reimbursed regulatory jurisdiction where applicable governmental authority approve determine price reimbursement pharmaceutical product style margin margin bottom text indent font size font family time roman product infringement defined section style margin margin bottom text indent font size font family time roman product mark meaning forth section style margin margin bottom text indent font size font family time roman project director defined section style margin margin bottom text indent font size font family time roman receiving party defined section style margin margin bottom text indent font size font family time roman regulatory approval mean approval including pricing approval necessary commercial sale licensed product field given country regulatory jurisdiction style margin margin bottom text indent font size font family time roman regulatory authority mean applicable government authority responsible granting regulatory approval licensed product including corresponding national regional regulatory authority style margin margin bottom text indent font size font family time roman regulatory material mean regulatory application submission notification communication correspondence registration other filing made received from otherwise conducted with regulatory authority order develop manufacture market sell otherwise commercialize licensed oligo licensed product field particular country jurisdiction regulatory material includes marketing approval application regulatory approval style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman remainder defined section style margin margin bottom text indent font size font family time roman remedial action defined section style margin margin bottom text indent font size font family time roman replacement target defined section style margin margin bottom text indent font size font family time roman research budget defined section style margin margin bottom text indent font size font family time roman research collaboration defined section style margin margin bottom text indent font size font family time roman research plan defined section style margin margin bottom text indent font size font family time roman research term defined section style margin margin bottom text indent font size font family time roman royalty term mean time period during which servier royalty payment obligation continues accordance with section style margin margin bottom text indent font size font family time roman santaris agreement mean that certain license agreement between santaris pharma santaris miragen dated june nbsp amended style margin margin bottom text indent font size font family time roman selected biomarkers defined section style margin margin bottom text indent font size font family time roman selected licensed product defined section style margin margin bottom text indent font size font family time roman servier companion diagnostic mean patent right know that nbsp controlled servier affiliate effective date during term nbsp reasonably necessary useful development manufacture importation sale companion diagnostic servier companion diagnostic shall include servier right joint that satisfies notwithstanding foregoing shall exclude nbsp patent right know that satisfy arose from unsponsored work performed servier unless until miragen reimburses servier such work accordance with section nbsp nbsp patent right know licensed servier affiliate pursuant license agreement entered into after effective date that additional third party companion diagnostic license style margin margin bottom text indent font size font family time roman servier indemnitee defined section style margin margin bottom text indent font size font family time roman servier know mean know included servier therapeutic servier companion diagnostic servier know shall include servier interest joint know style margin margin bottom text indent font size font family time roman servier patent mean patent right included servier therapeutic servier companion diagnostic servier patent shall include servier interest joint patent style margin margin bottom text indent font size font family time roman servier sample defined section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman servier sole patent defined section style margin margin bottom text indent font size font family time roman servier therapeutic mean patent right know that nbsp controlled servier affiliate effective date during term nbsp reasonably necessary useful development manufacture importation sale licensed oligos licensed product servier therapeutic shall include servier right joint that satisfies notwithstanding foregoing shall exclude nbsp patent right know that satisfy arose from unsponsored work performed servier unless until miragen reimburses servier such work accordance with section nbsp nbsp patent right know licensed servier affiliate pursuant license agreement entered into after effective date that additional third party therapeutic license style margin margin bottom text indent font size font family time roman target mean each three microrna target family identified below further described exhibit style margin margin bottom text indent font size font family time roman microrna unless party choose replacement target accordance with section nbsp which case replacement target style margin margin bottom text indent font size font family time roman microrna unless party choose replacement target accordance with section nbsp which case replacement target style margin margin bottom text indent font size font family time roman additional microrna target family selected party accordance with section nbsp third target unless party choose replacement target accordance with section nbsp which case replacement target style margin margin bottom text indent font size font family time roman target list defined section style margin margin bottom text indent font size font family time roman term defined section style margin margin bottom text indent font size font family time roman territory mean world except united state japan style margin margin bottom text indent font size font family time roman third party mean person other than party affiliate party style margin margin bottom text indent font size font family time roman third target defined section nbsp definition target style margin margin bottom text indent font size font family time roman agreement mean that certain exclusive technology license agreement between university north carolina chapel hill miragen dated august nbsp style margin margin bottom text indent font size font family time roman united state mean united state america including territory possession style margin margin bottom text indent font size font family time roman unsponsored work defined section style margin margin bottom text indent font size font family time roman unsponsored work development cost mean development cost incurred party conducting unsponsored work style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman upstream license agreement mean effective date santaris agreement agreement southwestern agreement upon selection third target party shall amend this definition necessary additional license agreement between miragen third party entered into before effective date pursuant which miragen sublicensable license miragen therapeutic that cover such third target licensed oligos that directly selectively modulate such third target upon selection replacement target party shall amend this definition necessary additional license agreement between miragen third party entered into before effective date pursuant which miragen sublicensable license miragen therapeutic that cover such replacement target licensed oligos that directly selectively modulate such third target upon selection replacement target party shall amend this definition remove license agreement between miragen third party pursuant which miragen sublicensable license intellectual property that longer miragen therapeutic because cover member microrna target family that replaced such replacement target licensed oligos that directly selectively modulate such member style margin margin bottom text indent font size font family time roman upstream licensors mean effective date santaris university north carolina chapel hill university texas system party shall amend this definition together with amendment definition upstream license agreement that entity included this definition third party that granted license miragen under agreement that then included definition upstream license agreement style margin margin bottom text indent font size font family time roman partner agreement defined section style margin margin bottom text indent font size font family time roman southwestern agreement mean those certain exclusive license agreement between university texas system miragen with following agreement number miragen dated april nbsp miragen dated april nbsp miragen dated april nbsp miragen dated april nbsp miragen dated february nbsp each foregoing agreement shall referred individually southwestern agreement style margin margin bottom text indent font size font family time roman valid claim mean with respect country nbsp claim issued unexpired patent extended through supplementary protection certificate patent term extension like that such time been revoked held invalid unenforceable patent office court other governmental agency competent jurisdiction final appealable judgment judgment from which appeal taken within allowable time period which claim such time been disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise nbsp pending claim unissued patent application which application such time been pending more than year since filing provided that such year period shall tolled duration proceeding opposition interference proceeding with respect such patent application style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman interpretation this agreement unless otherwise specified style margin margin bottom text indent font size font family time roman includes including shall mean respectively includes including without limitation style margin margin bottom text indent font size font family time roman word denoting singular shall include plural vice versa word denoting gender shall include gender style margin margin bottom text indent font size font family time roman word such herein hereof hereunder refer this agreement whole merely particular provision which such word appear style margin margin bottom text indent font size font family time roman exhibit other attachment form part operative provision this agreement reference this agreement shall include reference exhibit attachment style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center license style margin margin bottom text indent font size font family time roman license servier style margin margin bottom text indent font size font family time roman under miragen therapeutic subject term condition this agreement miragen hereby grant servier exclusive even miragen except provided section nbsp below royalty bearing licensable solely provided section nbsp license under miragen therapeutic style margin margin bottom text indent font size font family time roman perform servier obligation under research plan style margin margin bottom text indent font size font family time roman develop licensed product purpose obtaining regulatory approval field territory style margin margin bottom text indent font size font family time roman make have made licensed product solely field territory style margin margin bottom text indent font size font family time roman import offer sale sell licensed product field territory style margin margin bottom text indent font size font family time roman under miragen companion diagnostic style margin margin bottom text indent font size font family time roman subject term condition this agreement miragen hereby grant servier exclusive licensable solely provided section nbsp license under miragen companion diagnostic research develop companion diagnostics connection with licensed product field style margin margin bottom text indent font size font family time roman subject term condition this agreement miragen hereby grant servier solely with respect companion diagnostic associated licensed product which servier companion diagnostic contracting party exclusive right grant sublicense under miragen companion diagnostic third party contractor such third party contractor research develop such companion diagnostic solely connection with development commercialization such licensed product field pursuant this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman subject term condition this agreement miragen hereby grant servier with respect companion diagnostic associated licensed product exclusive licensable solely provided section nbsp license under miragen companion diagnostic nbsp make have made such companion diagnostic solely connection with development commercialization such licensed product field territory pursuant this agreement nbsp such companion diagnostic solely connection with development commercialization such licensed product field territory pursuant this agreement nbsp import offer sale sell such companion diagnostic territory solely connection with development commercialization such licensed product field territory pursuant this agreement style margin margin bottom text indent font size font family time roman license granted under this section nbsp shall royalty free except that party shall share cost additional third party companion diagnostic license agreement provided section nbsp style margin margin bottom text indent font size font family time roman servier acknowledges agrees that style margin margin bottom text indent font size font family time roman miragen obtained right certain miragen therapeutic miragen companion diagnostic under upstream license agreement style margin margin bottom text indent font size font family time roman license right granted miragen servier under section constitute sublicenses under upstream license agreement applicable style margin margin bottom text indent font size font family time roman such sublicenses subject subordinate term condition applicable upstream license agreement described exhibit which exhibit shall amended upon selection third target replacement target relevant term condition upstream license agreement delete term condition agreement which longer upstream license agreement style margin margin bottom text indent font size font family time roman servier shall comply only with those term upstream license agreement which specifically described exhibit which exhibit shall amended upon selection third target replacement target relevant term condition upstream license agreement delete term condition agreement which longer upstream license agreement style margin margin bottom text indent font size font family time roman servier shall have right develop commercialize licensed oligo licensed product outside field territory field outside territory servier desire expand license right granted under section above indication outside field territory servier shall notify miragen writing party shall negotiate good faith term condition upon which license right granted servier under section extended include such other indication party reach agreement such term condition then party shall amend this agreement reflect such term condition style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman sublicense right subject term condition this agreement style margin margin bottom text indent font size font family time roman servier exercise right perform obligation under this agreement itself through engagement affiliate without prior written consent miragen style margin margin bottom text indent font size font family time roman servier sublicense right granted under section nbsp more third party provided that concerning right granted under section nbsp such sublicensing shall subject prior written consent miragen such consent unreasonably withheld subject section servier subcontract third party performance task obligation with respect development manufacture licensed product servier deems appropriate grant limited sublicense such third party solely purpose performing such task obligation without prior written consent miragen notwithstanding foregoing miragen shall have right approve prior entry sublicense granted pursuant section nbsp style margin margin bottom text indent font size font family time roman servier shall remain responsible obligation under this agreement that have been delegated subcontracted sublicensed affiliate sublicensees subcontractor style margin margin bottom text indent font size font family time roman miragen retained right license miragen style margin margin bottom text indent font size font family time roman miragen retained right miragen affiliate hereby retain exclusive right under miragen therapeutic miragen companion diagnostic nbsp practice miragen therapeutic miragen companion diagnostic exercise right perform obligation under this agreement whether directly through more licensee nbsp practice license miragen therapeutic miragen companion diagnostic outside scope license granted servier under section including develop licensed product purpose obtaining regulatory approval outside territory make have made licensed product outside territory import offer sale sell licensed product outside territory each case foregoing subject without prejudice section nbsp style margin margin bottom text indent font size font family time roman license miragen under servier therapeutic subject term condition this agreement servier hereby grant miragen fully paid except expressly forth below sublicenseable through multiple tier license under servier therapeutic style margin margin bottom text indent font size font family time roman conduct miragen obligation under research plan style margin margin bottom text indent font size font family time roman develop licensed product purpose obtaining regulatory approval field outside territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman make have made licensed product solely field outside territory style margin margin bottom text indent font size font family time roman import offer sale sell licensed product field outside territory style margin margin bottom text indent font size font family time roman research develop make have made import offer sale sell licensed product outside field outside territory style margin margin bottom font size font family time roman such license shall nbsp with respect servier interest joint nbsp with respect servier therapeutic that generated pursuant development plan phase clinical trial licensed product provided however that miragen fails reimburse servier miragen share phase cost phase clinical trial provided section nbsp fails cure such breach within after receiving notice from servier servier shall have right terminate license granted under this section nbsp solely with respect servier therapeutic that generated such phase clinical trial nbsp with respect other servier therapeutic would style margin margin bottom text indent font size font family time roman license miragen under servier companion diagnostic style margin margin bottom text indent font size font family time roman subject term condition this agreement servier hereby grant miragen exclusive licensable license under servier companion diagnostic research develop companion diagnostics connection with licensed product style margin margin bottom text indent font size font family time roman subject term condition this agreement servier hereby grant miragen solely with respect companion diagnostic associated licensed product which miragen companion diagnostic contracting party exclusive right grant sublicense solely with servier prior approval which will unreasonably withheld under servier companion diagnostic third party contractor such third party contractor research develop such companion diagnostic solely connection with development commercialization such licensed product field pursuant this agreement style margin margin bottom text indent font size font family time roman subject term condition this agreement servier hereby grant miragen with respect companion diagnostic associated licensed product exclusive licensable through multiple tier license under servier companion diagnostic nbsp make have made such companion diagnostic solely connection with development commercialization such licensed product field outside territory pursuant this agreement nbsp such companion diagnostic solely connection with development commercialization such licensed product field outside territory pursuant this agreement nbsp import offer sale sell such companion diagnostic outside territory solely connection with development commercialization such licensed product field outside territory pursuant this agreement nbsp make have made import offer sale sell such companion diagnostic solely connection with development commercialization such licensed product outside field outside territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman license granted under this section nbsp shall royalty free except that party shall share cost additional third party companion diagnostic license agreement provided section nbsp style margin margin bottom text indent font size font family time roman implied license negative covenant except forth herein neither party shall acquire license other intellectual property interest implication otherwise under trademark patent patent application other party each party shall shall permit affiliate sublicensees practice patent right know licensed other party outside scope license granted under this agreement style margin margin bottom text indent font size font family time roman exclusivity during term neither servier miragen shall directly indirectly develop commercialize enter into collaboration license agreement with third party connection with development commercialization molecule product other than that provided however that retains right nbsp directly indirectly develop commercialize molecule product that nbsp directly indirectly develop commercialize molecule product other than provided such activity would clarity during term shall directly indirectly develop commercialize molecule product that addition long pursuant this agreement shall directly indirectly develop product that addition during term year thereafter neither servier miragen shall without consent other party pursuant research plan that that nbsp under research plan nbsp that pursuant research plan nbsp notwithstanding anything contrary this section nbsp this section nbsp shall prohibit either party after completion date from performing research development independently each other either alone together with nbsp third party nbsp upon molecule product that nbsp that pursuant research plan that that purpose this agreement completion date mean earlier nbsp date that nbsp first date after which style margin margin bottom text indent font size font family time roman right first negotiation additional target during first year after effective date miragen shall keep servier reasonably informed jrdc regarding other microrna target target family developed miragen affiliate alone collaboration with third party unless prevented agreement with such third party utility target oligonucleotides field additional target event that third party becomes miragen affiliate after effective date this section nbsp shall apply microrna target target family identified developed such entity before becomes miragen affiliate during such year period miragen wish grant third party license develop commercialize field oligonucleotide product that directly bind thereby modulate such additional target miragen shall promptly inform servier writing servier shall have confirm interest style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman license such additional target upon such confirmation interest miragen shall promptly disclose servier relevant data package such additional target servier shall have exclusive right during period following receipt such data package negotiate with miragen good faith regarding term condition separate agreement under which servier could receive exclusive license from miragen with respect such additional target servier notify miragen intention engage such negotiation within receipt such written notice such negotiation result binding written agreement such period then miragen shall free negotiate with third party with respect such license subject fourth sentence section nbsp grant such license third party without further obligation servier clarity obligation forth this section nbsp shall survive expiration termination this agreement further clarity right first negotiation forth this section nbsp addition exclusive selection third target replacement target pursuant section party evaluate select additional target third target replacement target pursuant section nbsp applicable this section nbsp shall apply additional target that selected third target replacement target style margin margin bottom text indent font size font family time roman additional third party therapeutic license either party desire obtain license intellectual property right that owned controlled third party reasonably necessary useful development manufacture commercialization more licensed product field then such party shall bring such matter attention shall discus whether advisable party obtain worldwide license which would sublicensed other party under term this agreement decides seek such worldwide license benefit both party shall designate party negotiate term which such license would granted serve primary point contact with such third party licensor upon approval license agreement designed party shall execute such license agreement each such agreement additional third party therapeutic license agreement intellectual property licensed pursuant additional third party therapeutic license agreement shall automatically included miragen therapeutic miragen contracting party servier therapeutic servier contracting party sublicensed other party under term this agreement each party shall responsible payment third party licensor under such additional third party therapeutic license agreement that specific territory example milestone payment regulatory approval territory royalty sale licensed product territory shall share equally payment third party licensor under such additional third party therapeutic license agreement that specific particular territory example upfront payment payment initiation clinical trial pursuant development plan clarity foregoing sentence shall interpreted depriving servier right pursuant section nbsp further clarity decides seek such worldwide license benefit both party either party enter into license agreement obtain license practice such third party intellectual property with respect development manufacture commercialization licensed product field territory pursuant this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman additional third party companion diagnostic license either party desire obtain license intellectual property right that owned controlled third party reasonably necessary useful development manufacture commercialization companion diagnostic connection with development commercialization licensed product field then such party shall bring such matter attention shall discus whether advisable party obtain worldwide license which would sublicensed other party under term this agreement decides seek such worldwide license benefit both party then companion diagnostic contracting party such companion diagnostic shall negotiate term which such license would granted serve primary point contact with such third party licensor upon approval license agreement companion diagnostic contracting party shall execute such license agreement each such agreement additional third party companion diagnostic license agreement intellectual property licensed pursuant additional third party diagnostic license agreement shall automatically included miragen companion diagnostic miragen contracting party servier companion diagnostic servier contracting party sublicensed other party under term this agreement each party shall responsible payment third party licensor under such additional third party companion diagnostic license agreement that specific territory example milestone payment regulatory approval territory royalty sale companion diagnostic territory shall share payment third party licensor under such additional third party companion diagnostic license agreement that specific particular territory example upfront payment payment initiation clinical trial companion diagnostic used clinical trial licensed product pursuant development plan part companion diagnostic development cost pursuant section nbsp further clarity decides seek such worldwide license benefit both party either party enter into license agreement obtain license practice such third party intellectual property with respect development manufacture commercialization companion diagnostic connection with development commercialization licensed product field territory pursuant this agreement style margin margin bottom text indent font size font family time roman miragen acquiror miragen undergoes change control during term such change control cause third party miragen acquiror become affiliate successor miragen date closing change control transaction miragen acquiror owns control intellectual property right that reasonably necessary development manufacture commercialization licensed product field such licensed product exists such date subsequent modification thereof that approved miragen development manufacture commercialization companion diagnostic connection with development commercialization licensed product such companion diagnostic exists such date subsequent modification thereof that approved miragen field such intellectual property right acquiror right grant servier license under acquiror scope forth section nbsp then servier request identifying acquiror that wish license provided that such request made within style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman hundred twenty nbsp after notification relevant nbsp such acquiror relates companion diagnostic miragen acquiror shall notify servier amount that miragen acquiror obligated third party connection with license granted servier such scope servier agrees writing reimburse miragen such cost party shall amend this agreement include such acquiror miragen companion diagnostic addition cost nbsp such acquiror relates licensed product miragen acquiror servier shall negotiate good faith increase royalty rate section nbsp such license such acquiror provided however that increase royalty rate shall shall miragen acquiror servier agree such royalty rate increase servier agrees party shall amend this agreement include such acquiror miragen therapeutic notwithstanding foregoing miragen acquiror only exclusive right acquiror miragen acquiror already granted more exclusive license third party under acquiror then license granted servier under such acquiror shall exclusive only with respect miragen acquiror remaining right such acquiror clarity miragen acquiror shall obligated grant license servier under acquiror grant such license will cause miragen acquiror breach agreement which party which bound provided that such case extent permitted such agreement miragen shall shall procure that affiliate miragen acquiror shall bring claim suit other proceeding against servier affiliate their respective licensee sublicensees before court alleging that development manufacture commercialization licensed product field territory development manufacture commercialization companion diagnostic connection with development commercialization licensed product field territory infringes such acquiror further clarity nbsp servier request within hundred twenty nbsp after notification relevant negotiation obtain license particular acquiror nbsp servier agree reimburse cost incurred miragen granting such license servier under companion diagnostics related acquiror nbsp miragen acquiror servier agree upon royalty rate increase license licensed product related acquiror servier agree then miragen acquiror shall retain right enforce permit others enforce such acquiror against servier affiliate sublicensees with respect infringement misappropriation such acquiror purpose this section nbsp notification relevant mean written notification sent miragen servier time during term that identifies patent number patent application publication number other reasonable information requested servier within thirty nbsp after receipt such notice intellectual property right which miragen belief satisfies definition acquiror sake clarity this section nbsp shall interpreted requiring either miragen miragen acquiror review miragen acquiror intellectual property portfolio identify acquiror contained therein provided however that nbsp miragen acquiror shall enforce acquiror against servier affiliate sublicenses with respect development manufacture commercialization servier affiliate sublicenses during term licensed product described this section nbsp field territory until miragen provided servier with notification relevant that identifies such acquiror hundred twenty nbsp period after such notification relevant style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman expired nbsp prior assigning granting third party right under particular intellectual property miragen acquiror miragen shall reasonably determine that such miragen acquiror intellectual property satisfy definition acquiror style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center governance style margin margin bottom text indent font size font family time roman alliance business development manager within thirty nbsp following effective date each party shall appoint notify other party identity representative business development alliance manager under this agreement alliance business development manager alliance business development manager shall coordinate business related activity under this agreement alliance business development manager shall attend meeting bring matter relation business attention committee such alliance business development manager reasonably belief that such matter warrant such attention each party replace alliance business development manager written notice other party style margin margin bottom text indent font size font family time roman alliance manager within thirty nbsp following effective date each party shall appoint notify other party identity representative alliance research development manager under this agreement alliance manager regard research development activity alliance manager shall serve primary contact point between party shall primarily responsible facilitating flow information interaction collaboration between party shall responsible ensuring that governance procedure rule forth herein complied with alliance manager shall attend meeting joint research development committee joint steering committee bring matter relation alliance research development management attention committee such alliance manager reasonably belief that such matter warrant such attention each party replace alliance manager written notice other party style margin margin bottom text indent font size font family time roman project director within thirty nbsp following effective date each party shall appoint notify other party identity representative project director project director project director shall responsible follow respective research development activity under this agreement regular basis project director shall attend meeting joint research development committee bring matter relation project management attention joint steering committee such project director reasonably belief that such matter warrant such attention each party replace project director written notice other party style margin margin bottom text indent font size font family time roman joint executive committee party shall establish joint executive committee joint executive committee composed three nbsp senior executive from each party shall manage overall collaboration party under this agreement including intellectual property strategy resource allocation major change collaboration requiring amendment agreement resolve disputed matter style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman joint steering committee party shall establish joint steering committee joint steering committee composed each party alliance business development manager alliance manager nbsp senior executive each party shall nbsp oversee research collaboration development manufacture commercialization licensed product field territory nbsp review approve annual interim amendment research plan including research budget development plan including development budget nbsp upon proposal jrdc select each licensed product which impd enabling toxicology study shall initiated each selected licensed product review approve development plan proposed jrdc such selected licensed product nbsp advisability necessity developing companion diagnostic licensed product field upon determining that companion diagnostic advisable necessary such licensed product field upon proposal jrdc select each biomarker combination biomarkers development companion diagnostic selected biomarkers develop plan engaging third party contractor research develop such companion diagnostic field both within outside territory decide which party which contemplated effective date miragen will responsible engaging such third party such party companion diagnostic contracting party such companion diagnostic licensed product nbsp discus resolve dispute with respect conduct collaboration nbsp establish additional joint subcommittee appropriate nbsp consider upon such other matter specified agreement nbsp resolve disputed matter jrdc style margin margin bottom text indent font size font family time roman joint research development committee party shall establish joint research development committee joint research development committee jrdc composed three nbsp representative each party that have knowledge expertise field development product similar licensed product jrdc shall oversee research development activity party under research plan development plan recommend amendment research plan including research budget development plan including development budget such activity shall include recommending choice selected licensed product selected biomarkers jrdc shall review approve detailed protocol study which already included research plan development plan style margin margin bottom text indent font size font family time roman limitation committee authority each committee shall only have power expressly assigned this article elsewhere this agreement shall have authority nbsp modify amend term condition this agreement nbsp waive either party compliance with term condition under this agreement nbsp determine such issue manner that would conflict with express term condition this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman committee membership meeting style margin margin bottom text indent font size font family time roman committee member within thirty nbsp following effective date each party shall designate initial member serve each committee each party replace representative committee written notice other party each party shall appoint nbsp representative each committee chairperson such committee chairperson shall jointly prepare circulate agenda reasonably detailed minute each committee meeting style margin margin bottom text indent font size font family time roman meeting each committee shall hold meeting such time elect event shall such meeting held frequently than once every nbsp month once every four nbsp month jrdc clarity party anticipate holding meeting promptly after jrdc submits initial updated amended research plan development plan review approval meeting committee held person audio video teleconference provided that least nbsp meeting year each committee shall held person person committee meeting shall held location selected alternatively party each party shall responsible expense participating committee action taken meeting committee shall effective unless representative each party participating style margin margin bottom text indent font size font family time roman member attendance each party from time time invite reasonable number participant addition representative attend committee meeting font style white space nowrap voting font capacity provided that either party intends have third party including consultant attend such meeting such third party shall bound confidentiality obligation consistent with term this agreement style margin margin bottom text indent font size font family time roman decision making decision each committee shall made unanimous vote with each party representative collectively having nbsp vote after reasonable discussion good faith consideration each party view particular matter before committee representative party reach agreement such matter within thirty nbsp after such matter brought such committee resolution after such matter been referred such committee such disagreement shall referred case disagreement jrdc case disagreement chief executive officer miragen chief executive officer servier designee executive officer case disagreement resolution executive officer resolve such matter within thirty nbsp after such matter been referred them then that subject dispute clarity executive officer resolve such matter that pertains will obligated further clarity executive officer resolve such matter that pertains neither party shall obligated notwithstanding foregoing provision provision contrary shall have final with respect decision which involves including example whether whether neither party shall obligated account which exercised such final unless agreed executive officer nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman discontinuation participation committee activity performed each committee shall solely relate governance under this agreement shall involve delivery service each committee shall continue exist until first occur nbsp party mutually agreeing disband committee nbsp miragen providing written notice servier intention disband longer participate such committee once party mutually agree miragen provided written notice disband such committee such committee shall have further obligation under this agreement thereafter alliance business development manager alliance manager project director shall contact person exchange information under this agreement decision such committee shall decision between party subject other term condition this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center research style margin margin bottom text indent font size font family time roman general subject term condition this agreement party desire establish research collaboration where servier will fund party will conduct research activity pursuant research plan agreed upon party directed identification characterization microrna target oligonucleotides field such research plan research plan such collaboration research collaboration style margin margin bottom text indent font size font family time roman research term initial term research collaboration research term shall three year period after effective date upon mutual agreement party research term extended nbsp additional year period style margin margin bottom text indent font size font family time roman research plan research activity activity prior initiation impd enabling toxicology study under this agreement shall conducted party pursuant research plan research plan shall allocate research responsibility between party shall forth timeline detail research activity conducted each party which shall include limited nbsp nbsp nbsp nbsp nbsp research plan shall also forth budget research activity carried miragen research budget effective date party have agreed upon initial research plan attached this agreement exhibit soon advisable during research term than once year jrdc shall prepare update amendment appropriate then current research plan including research budget shall submit such update amendment review approval once approved such revised research plan shall replace prior research plan term research plan contradict create inconsistency ambiguity with term this agreement then term this agreement shall govern style margin margin bottom text indent font size font family time roman conduct research research cost each party shall commercially reasonable effort carry activity assigned research plan shall conduct such activity good scientific manner compliance with applicable each party shall keep other party reasonably informed progress conduct research plan through meeting jrdc servier shall responsible cost expense incurred both party performing research plan shall reimburse miragen cost expense incurred account miragen performing research plan pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman selection third target jrdc shall review discus result data from conduct research plan meeting shall maintain list target list least microrna target family proposed miragen being specified that servier shall also entitled propose microrna target family inclusion target list jrdc shall update target list from time time exclude microrna target family that either subject bona fide internal research development program miragen outside field subject obligation miragen third party that would prevent miragen from granting right servier such microrna target family contemplated this agreement jrdc shall also rank microrna target family target list order preference based safety efficacy intellectual property status other relevant factor provided that case jrdc reach agreement such order preference servier shall have final later than month after effective date servier shall notify miragen writing that microrna target family target list ready submission santaris order preference then effect inclusion santaris agreement promptly after receipt such notice miragen shall submit microrna target family target list with highest ranking santaris inclusion santaris agreement such microrna target family accepted santaris miragen shall submit microrna target family target list with next highest ranking santaris until microrna target family target list accepted santaris inclusion santaris agreement upon acceptance santaris inclusion santaris agreement such microrna target family shall selected third target under this agreement party shall promptly update amend research plan development plan include research development activity related third target style margin margin bottom text indent font size font family time roman replacement target style margin margin bottom text indent font size font family time roman effective date microrna target family microrna target family target pursuant activity forth research plan party shall through jrdc further evaluate suitability microrna target family microrna target family target jrdc decision case disagreement servier decision whether each microrna target family microrna target family suitable target shall made based nbsp more following four nbsp criterion nbsp licensed oligos that directly selectively modulate target nbsp licensed oligos that directly selectively modulate target nbsp licensed oligos that directly selectively modulate target nbsp style margin margin bottom text indent font size font family time roman based result obtained from activity forth research plan criterion forth above section nbsp jrdc servier case determines that microrna target family microrna target family remain suitable target then microrna target family microrna target family applicable shall remain target under this agreement term condition applicable such target under this agreement shall remain unchanged style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman after selection third target party decide further evaluate suitability third target target based criterion forth above section nbsp which criterion shall apply mutatis mutandis evaluation suitability third target target jrdc servier case determines that third target remains suitable target then third target shall remain target under this agreement term condition applicable such target under this agreement shall remain unchanged style margin margin bottom text indent font size font family time roman based result obtained from activity forth research plan criterion forth above section nbsp jrdc servier case determines that microrna target family microrna target family third target suitable target then microrna target family microrna target family third target applicable shall longer deemed target hereunder jrdc shall select microrna target family from target list replacement such target such replacement replacement target provided however that case jrdc reach agreement such selection servier shall have final upon selection replacement target style margin margin bottom text indent font size font family time roman servier license right under this agreement pertaining microrna target family microrna target family third target applicable shall terminate style margin margin bottom text indent font size font family time roman such replacement target shall deemed target hereunder style margin margin bottom text indent font size font family time roman party shall update amend research plan development plan exclude research development activity related microrna target family microrna target family third target applicable include research development activity related such replacement target style margin margin bottom text indent font size font family time roman servier hereby assigns miragen effective such jrdc determination right title interest invention related microrna target family microrna target family third target applicable well data result generated servier course work performed pursuant this agreement with respect microrna target family microrna target family third target applicable style margin margin bottom text indent font size font family time roman such invention data result shall deemed confidential information miragen style margin margin bottom text indent font size font family time roman servier shall promptly transfer tangible electronic embodiment such invention data result miragen style margin margin bottom text indent font size font family time roman miragen shall have right research develop commercialize product pertaining microrna target family microrna target family third target applicable component therein field anywhere either itself collaboration with third party without further obligation servier style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman viii miragen shall commercially reasonable effort either nbsp amend santaris agreement include such replacement target nbsp party decides incorporate lieu santaris technology alternative chemistry having drug like property into licensed product directed such replacement target enter into third party agreement obtain license such alternative technology with respect such replacement target which license sublicensed servier without further payment servier under term this agreement clarity shall breach this agreement miragen after using commercially reasonable effort fails include replacement target santaris agreement fails obtain third party license alternative technology that cover replacement target style margin margin bottom text indent font size font family time roman party right evaluate suitability each microrna target family microrna target family third target target either them decided pursuant section nbsp suitable target replace with replacement target pursuant section nbsp shall expire period immediately following effective date longer period agreed writing party clarity replacement target replaced style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center development style margin margin bottom text indent font size font family time roman general style margin margin bottom text indent font size font family time roman subject term condition this agreement party desire collaborate with respect development licensed product field share data resulting from such collaboration facilitate development licensed product field style margin margin bottom text indent font size font family time roman servier acknowledges understands that miragen sole discretion enter into more agreement with third party grant such third party right develop commercialize licensed product outside territory each such third party miragen partner each such agreement miragen partner agreement miragen enters into such miragen partner agreement with third party that refused servier pursuant section nbsp allow miragen disclose servier confidential information then miragen shall have right obligation grant such miragen partner such miragen partner approved miragen partner right participate development licensed product serve representative miragen more committee established under this agreement servier shall cooperate fully with such approved miragen partner with respect development licensed product extent that servier obligation under this agreement cooperate with miragen such activity miragen shall have right disclose such approved miragen partner information regarding licensed product regulatory material disclosed servier miragen under this agreement such approved miragen style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman partner development commercialization licensed product outside territory consistent with section nbsp article addition miragen shall have right obligation exercise fulfill following right obligation through such approved miragen partner style margin margin bottom text indent font size font family time roman conduct development activity assigned miragen under development plan style margin margin bottom text indent font size font family time roman review copy servier development record provided section nbsp style margin margin bottom text indent font size font family time roman receive data generated behalf servier course performing development plan unsponsored work provided section nbsp style margin margin bottom text indent font size font family time roman prepare submit regulatory material licensed product outside territory provided section nbsp style margin margin bottom text indent font size font family time roman review comment regulatory material received prepared behalf servier provided section nbsp style margin margin bottom text indent font size font family time roman attend meeting with regulatory authority that relate development licensed product territory provided section nbsp style margin margin bottom text indent font size font family time roman right reference regulatory material pertaining licensed product field that submitted behalf servier seek obtain maintain regulatory approval licensed product outside territory provided section nbsp style margin margin bottom text indent font size font family time roman viii initiate control remedial action outside territory provided section nbsp style margin margin bottom text indent font size font family time roman manufacture supply licensed oligos licensed product provided section nbsp style margin margin bottom text indent font size font family time roman prosecute enforce miragen patent servier patent provided section nbsp section nbsp style margin margin bottom text indent font size font family time roman disclose servier confidential information provided section style margin margin bottom text indent font size font family time roman development plan development each licensed product field under this agreement shall conducted pursuant comprehensive written development plan development plan each development plan shall forth timeline detail clinical clinical development activity nbsp conducted party necessary generate data useful both party obtain regulatory approval such licensed product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman both indication field that party agree pursue nbsp other development activity that party agree pursue collaboration such licensed product field territory development plan shall also forth budget such development activity carried party development budget effective date party have agreed upon sample development plan particular licensed product that directly selectively modulates target that member microrna target family which plan attached this agreement exhibit includes only clinical development activity such licensed product shall updated provided below jrdc shall prepare submit review approval initial development plan each selected licensed product promptly upon jrdc selection such selected licensed product from time time during term than once year jrdc shall prepare update amendment appropriate each then current development plan including development budget shall submit such update amendment review approval once approved each such revised development plan shall replace prior development plan such licensed product term development plan contradict create inconsistency ambiguity with term this agreement then term this agreement shall govern style margin margin bottom text indent font size font family time roman allocation development responsibility style margin margin bottom text indent font size font family time roman each development plan shall reasonably allocate development responsibility relevant licensed product field between party provided that servier shall regulatory sponsor clinical study licensed product field conducted territory miragen shall regulatory sponsor clinical study licensed product field conducted outside territory style margin margin bottom text indent font size font family time roman party interested pursuing additional development work particular licensed product field that then included development plan such licensed product then such party shall submit other party reasonably detailed plan such development work then style margin margin bottom text indent font size font family time roman other party also interested pursuing such development work party shall amend applicable development plan include such additional development work party shall share development plan cost incurred party connection with conduct such development work accordance with section nbsp style margin margin bottom text indent font size font family time roman other party interested pursuing such development work nbsp reasonably object such development work likely having material adverse effect upon procurement maintenance regulatory approval commercialization licensed product territory nbsp such development work required other regulatory authority other country within territory case servier case miragen then such party shall have right perform such development work unsponsored work cost expense such unsponsored work shall included applicable development plan subject party sharing development plan cost each party shall have sole discretion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman conduct unsponsored work provided that each party shall keep other party informed progress such unsponsored work through jrdc providing soon available least draft protocol final protocol list investigator center line result final result dispute over whether such development work likely have material adverse effect upon procurement maintenance regulatory approval commercialization licensed product territory shall resolved pursuant section nbsp except forth section nbsp data resulting from such unsponsored work will shared with other party solely necessary such other party comply with regulatory requirement particular with respect safety reporting licensed product such other party territory style margin margin bottom text indent font size font family time roman addition miragen shall have right conduct discretion cost expense development work licensed product purpose obtaining regulatory approval such licensed product outside field outside territory unless servier reasonably object such work likely having material adverse effect upon procurement maintenance regulatory approval commercialization such licensed product field territory such development work shall included development plan subject party sharing development plan cost data resulting from such development work will shared with servier solely necessary servier comply with regulatory requirement particular with respect safety reporting licensed product territory style margin margin bottom text indent font size font family time roman development cost style margin margin bottom text indent font size font family time roman phase cost servier shall responsible development plan cost that incurred party through completion phase clinical trial that companion diagnostic development cost phase cost licensed product shall reimburse phase cost incurred miragen pursuant section nbsp style margin margin bottom text indent font size font family time roman phase cost development plan cost that incurred party preparing conducting analyzing phase clinical trial that companion diagnostic development cost phase cost each licensed product shall allocated between party follows style margin margin bottom text indent font size font family time roman nbsp miragen enters into agreement with third party grant such third party right develop commercialize licensed product field partner agreement least before initiation first phase clinical trial such licensed product nbsp miragen notifies servier least before initiation first phase clinical trial that wish share cost such phase clinical trial subsequent phase clinical trial such licensed product then servier miragen shall responsible phase cost such licensed product forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman miragen enter into partner agreement least before initiation first phase clinical trial licensed product then servier shall responsible such phase cost such licensed product shall reimburse such phase cost incurred miragen pursuant section nbsp miragen shall reimburse servier part such phase cost follows pursuant section nbsp style margin margin bottom text indent font size font family time roman miragen subsequently enters into partner agreement before completion phase clinical trial such licensed product then miragen shall promptly reimburse servier phase cost such licensed product incurred servier prior miragen entry into such partner agreement miragen shall continue reimburse servier phase cost such licensed product incurred servier thereafter with respect phase clinical trial style margin margin bottom text indent font size font family time roman miragen enter into partner agreement before completion phase clinical trial such licensed product then miragen shall reimburse servier phase cost such licensed product incurred servier with respect such phase clinical trial upon miragen filing such licensed product which includes data from such phase clinical trial style margin margin bottom text indent font size font family time roman purpose this section nbsp mean style margin margin bottom text indent font size font family time roman unsponsored work development cost each party shall solely responsible unsponsored work development cost incurred such party provided that other party desire data resulting from such development work purpose other than complying with regulatory reporting requirement such other party territory such other party shall reimburse party conducting such development work unsponsored work development cost incurred such party course conducting development work that generated such data style margin margin bottom text indent font size font family time roman companion diagnostic development cost style margin margin bottom text indent font size font family time roman subject section nbsp below servier shall responsible development plan cost incurred party development each companion diagnostic pursuant development plan companion diagnostic development cost shall reimburse such companion diagnostic development cost incurred miragen pursuant section nbsp style margin margin bottom text indent font size font family time roman miragen shall reimburse servier part such companion diagnostic development cost follows pursuant section nbsp miragen nbsp enters into agreement with third party grant such third party right import offer sale sale such companion diagnostic outside territory nbsp enters into partner agreement licensed product associated with such companion diagnostic nbsp time during development companion diagnostic notifies servier writing that miragen will reimburse servier part companion diagnostic development cost such companion diagnostic then miragen shall upon first occur nbsp reimburse servier companion diagnostic development cost such companion diagnostic incurred servier prior such notice thereafter miragen shall reimburse servier quarterly basis companion diagnostic development cost such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman companion diagnostic incurred servier after such notice none nbsp nbsp occurs before miragen filing regulatory approval application such companion diagnostic then miragen shall reimburse servier companion diagnostic development cost such companion diagnostic incurred servier style margin margin bottom text indent font size font family time roman diligence each party shall commercially reasonable effort conduct development activity assigned under development plan without limiting foregoing servier shall commercially reasonable effort develop least licensed product each target field shall commercially reasonable effort pursue regulatory approval each such licensed product each major market country indication that will maximize profitability such licensed product total profit basis unit basis servier affiliate sublicensee whichever selling party such licensed product subject foregoing sentence servier shall entitled time discontinue development licensed product provided that nbsp servier shall commercially reasonable effort develop least other licensed product same target discontinued licensed product nbsp servier shall send prior written notice that effect miragen least three nbsp month prior effective date termination development such licensed product except where such termination safety reason pursuant section style margin margin bottom text indent font size font family time roman development record each party shall maintain complete current accurate record development activity conducted hereunder data other information resulting from such activity such record shall fully properly reflect work done result achieved performance development activity good scientific manner appropriate regulatory patent purpose each party shall document clinical study clinical trial formal written study report according applicable national international guideline each party shall have right review copy such record maintained other party reasonable time obtain access original extent necessary regulatory patent purpose other legal proceeding connection with sharing data result forth section style margin margin bottom text indent font size font family time roman mutual data exchange addition adverse event safety data reporting obligation pursuant section nbsp each party shall promptly provide other party with copy data result generated behalf such party course performing development plan unsponsored work party receiving such data shall have right reference such data nbsp purpose obtaining maintaining regulatory approval licensed product field territory nbsp where miragen receiving party purpose obtaining maintaining regulatory approval licensed product outside field outside territory provided such activity would reasonably likely have material adverse effect upon procurement maintenance regulatory approval commercialization licensed product territory provided however that data resulting from unsponsored work only used receiving party comply with regulatory requirement particular with respect safety reporting such receiving party territory unless receiving party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman reimburse other party portion unsponsored work development cost forth section nbsp each party shall provide jrdc with regular report detailing development activity licensed product pursuant development plan well unsponsored work conducted such party result such activity each regularly scheduled jrdc meeting party shall discus status progress result each party development activity under development plan well unsponsored work conducted such party such jrdc meeting style margin margin bottom text indent font size font family time roman compliance subcontractor each party agrees that performing obligation exercising right under this agreement nbsp shall comply material respect with applicable nbsp shall employ engage person been debarred regulatory authority such party knowledge subject debarment proceeding regulatory authority party shall comply with pharmacovigilance procedure forth section nbsp further agreed writing party course developing manufacturing commercializing licensed product hereunder each party shall have right engage subcontractor purpose conducting activity assigned under development plan provided that such subcontractor bound written obligation confidentiality consistent with this agreement agreed assign party engaging such subcontractor invention made such subcontractor course performing such subcontracted work that relate licensed oligos licensed product their manufacture sale each party shall remain responsible obligation under development plan that have been delegated subcontracted subcontractor shall responsible performance subcontractor style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center regulatory style margin margin bottom text indent font size font family time roman regulatory responsibility development plan shall forth regulatory strategy seeking regulatory approval licensed product both indication field that party agree pursue jointly servier shall responsible preparation submission regulatory material licensed product field territory shall such regulatory material miragen shall responsible preparation submission regulatory material licensed product outside territory shall such regulatory material each party shall commercially reasonable effort carry regulatory activity assigned development plan cost associated with regulatory activity licensed product excluding filing maas shall included development plan cost such licensed product allocated between party accordance with section nbsp unless party otherwise agree writing neither party shall submit regulatory material communicate with regulatory authority outside territory except required applicable which case such party shall immediately provide notice such requirement other party prior such submission communication style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cooperation each party shall send regulatory material case servier only draft form other party give latter reasonable period time exceeding twenty comment such draft regulatory material each party shall notify other party regulatory material other than routine correspondence submitted received from regulatory authority respectively outside territory miragen servier shall provide other party with copy thereof style margin margin bottom text indent font size font family time roman meeting with regulatory authority each party shall provide other party with reasonable advance notification person meeting teleconference with regulatory authority territory that relates development licensed product field under development plan other party shall have right obligation have representative attend unless otherwise requested other party participate such meeting first party territory style margin margin bottom text indent font size font family time roman adverse event reporting least nbsp month prior expected date filing first with respect licensed product party shall discus good faith enter before such filing into pharmacovigilance adverse event reporting agreement setting forth worldwide pharmacovigilance procedure party with respect licensed product such safety data sharing adverse event reporting prescription event monitoring pharmacovigilance agreement such procedure shall accordance with enable party fulfill local national regulatory reporting obligation under applicable servier shall maintain adverse event database licensed product territory cost shall responsible reporting quality complaint adverse event safety data related licensed product applicable regulatory authority territory well responding safety issue request regulatory authority related licensed product territory each party hereby agrees comply with respective obligation under pharmacovigilance agreement cause affiliate licensee sublicensees comply with such obligation style margin margin bottom text indent font size font family time roman harmful action either party belief that other party case taking intends take action with respect licensed product that could reasonably expected have material adverse impact upon regulatory status licensed product territory such party shall have right bring matter attention jrdc party shall discus good faith resolve such concern first party style margin margin bottom text indent font size font family time roman notification threatened action each party shall immediately notify other party information receives regarding threatened pending action inspection communication regulatory authority which affect safety efficacy claim licensed product continued marketing licensed product field upon receipt such information party shall consult with each other effort arrive mutually acceptable procedure taking appropriate action style margin margin bottom text indent font size font family time roman right reference regulatory material each party hereby grant other party right reference regulatory material pertaining licensed product field submitted behalf such party servier such right reference style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman miragen regulatory material field solely purpose seeking obtaining maintaining regulatory approval licensed product field territory miragen right reference servier regulatory material field solely purpose seeking obtaining maintaining regulatory approval licensed product outside territory notwithstanding foregoing each party right reference regulatory material based data resulting from unsponsored work conducted other party only comply with regulatory requirement particular with respect safety reporting such party territory unless such party reimburse other party portion unsponsored work development cost forth section nbsp style margin margin bottom text indent font size font family time roman remedial action each party shall notify other immediately promptly confirm such notice writing obtains information indicating that licensed product field subject recall corrective action other regulatory action with respect licensed product field taken virtue applicable remedial action party shall assist each other gathering evaluating such information necessary determine necessity conducting remedial action each party shall shall ensure that affiliate sublicensees will maintain adequate record permit party trace manufacture licensed product distribution licensed product each party shall have sole discretion with respect matter relating remedial action territory including decision commence such remedial action control over such remedial action cost expense except extent such remedial action attributed compliance conformity licensed product supplied such party other party which case party that supplied such defective licensed product shall bear cost expense connection with such remedial action style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center manufacturing style margin margin bottom text indent font size font family time roman manufacture supply style margin margin bottom text indent font size font family time roman research clinical supply miragen shall either itself through third party manufacturer manufacture supply licensed oligos miragen servier conduct research plan clinical study under development plan style margin margin bottom text indent font size font family time roman clinical supply servier shall primarily responsible manufacturing supplying bulk licensed oligos finished licensed product clinical study conducted pursuant development plan field territory provided that servier engage miragen such manufacture supply follows least prior anticipated filing first first indication with respect licensed product servier shall notify miragen writing whether desire engage miragen such manufacture supply servier chooses have miragen provide such clinical supply servier miragen shall negotiate good faith enter into separate supply agreement having mutually agreed term with respect such clinical supply which supply shall cost good except unsponsored work which case supply shall cost good plus clarity miragen manufacturing related development cost described section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman included cost good shall included development plan cost shared party pursuant section nbsp servier engage miragen elect manufacture supply bulk licensed oligos finished licensed product development purpose either through itself third party manufacturer then miragen shall have right purchase such bulk licensed oligos finished licensed product from servier cost good except unsponsored work which case supply shall cost good plus other term condition agreed upon party forth separate supply agreement clarity miragen shall have right manufacture have manufactured anywhere world licensed oligos licensed product clinical commercial outside territory style margin margin bottom text indent font size font family time roman commercial supply servier shall solely responsible manufacturing supplying bulk licensed oligos finished licensed product commercial field territory miragen shall solely responsible manufacturing supplying bulk licensed oligos finished licensed product commercial field outside territory style margin margin bottom text indent font size font family time roman transfer manufacturing know servier notifies miragen that chooses manufacture clinical commercial supply licensed oligos licensed product miragen shall make available servier miragen know that then being used miragen third party manufacturer manufacture licensed oligos licensed product addition miragen shall provide reasonable technical assistance requested servier connection with such technology transfer servier shall responsible cost expense incurred miragen performing such technology transfer including fully burdened cost miragen personnel directly involved such technology transfer allocated effort spent such technology transfer provided such cost expense detailed mutually agreed budget prior technology transfer requested miragen later stage servier shall make available miragen servier know that then being used servier third party manufacturer manufacture licensed oligos licensed product addition servier shall provide reasonable technical assistance requested miragen connection with such technology transfer miragen shall responsible cost expense incurred servier performing such technology transfer including fully burdened cost servier personnel directly involved such technology transfer allocated effort spent such technology transfer provided such cost expense detailed approved budget prior technology transfer style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center commercialization style margin margin bottom text indent font size font family time roman commercialization territory subject term condition this article servier shall responsible aspect commercialization licensed product field territory servier shall bear cost expense incurred connection with such commercialization activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercialization plan servier shall pursue commercialization product territory accordance with normal business practice internal product similar stage servier shall deliver initial commercialization plan miragen later than twelve nbsp month prior anticipated date first filing first licensed product territory commercialization plan after establishment initial commercialization plan servier shall prepare update amendment such commercialization plan least annually deliver such updated commercialization plan miragen later than october nbsp each year style margin margin bottom text indent font size font family time roman commercial diligence servier shall commercially reasonable effort commercialize each licensed product nbsp each major market country outside which receives regulatory approval nbsp least three following country france germany italy provided that received regulatory approval unless launch particular licensed product more than these three country could reasonably expected have negative effect commercialization such licensed product other country which case servier shall commercially reasonable effort commercialize such licensed product remaining country these three country style margin margin bottom text indent font size font family time roman patent marking servier shall mark licensed product accordance with applicable patent marking shall require affiliate sublicensees same extent required applicable servier shall indicate licensed product packaging advertisement promotional material that licensed product licensed from miragen style margin margin bottom text indent font size font family time roman diversion each party hereby covenant agrees that shall shall ensure that affiliate sublicensees will either directly indirectly promote market distribute import sell have sold licensed product including internet mail order third party address internet protocol address other party territory such country other party territory nbsp such party shall engage advertising promotional activity relating licensed product directed primarily customer other buyer user licensed product located such country nbsp such party shall solicit order from prospective purchaser located such country party receives order from prospective purchaser located country other party territory such party shall immediately refer that order such other party shall accept such order neither party deliver tender cause delivered tendered licensed product other party territory style margin margin bottom text indent font size font family time roman report servier shall update once year october regarding servier commercialization activity with respect licensed product territory each such update shall form agreed shall summarize servier affiliate sublicensees significant commercialization activity with respect licensed product territory covering subject matter level detail reasonably required miragen sufficient enable miragen determine servier compliance with diligence obligation pursuant section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center financial provision style margin margin bottom text indent font size font family time roman upfront payment servier shall miragen time refundable creditable upfront payment million euro nbsp upon signature agreement within business receipt corresponding invoice style margin margin bottom text indent font size font family time roman reimbursement research cost within after each calendar quarter research term miragen shall submit servier reasonably detailed invoice setting forth cost expense incurred miragen such calendar quarter conducting research plan such cost expense shall include cost ftes miragen current rate that performed research activity forth research plan well pocket cost allocable such research activity miragen fully burdened cost manufacturing supplying procuring supply licensed oligos research plan each case extent such cost exceed research budget more than unless approved writing jrdc otherwise approved jrdc servier shall miragen amount invoiced within after receipt invoice style margin margin bottom text indent font size font family time roman reimbursement share development cost style margin margin bottom text indent font size font family time roman phase cost within after each calendar quarter before completion phase clinical trial licensed product miragen shall submit servier reasonably detailed invoice setting forth phase cost incurred miragen such calendar quarter servier shall miragen amount invoiced within after receipt invoice style margin margin bottom text indent font size font family time roman phase cost style margin margin bottom text indent font size font family time roman miragen servier required share phase cost forth section nbsp then within after each calendar quarter during which party conducting phase clinical trial licensed product each party shall submit other party reasonably detailed report setting forth phase cost incurred such party such calendar quarter within after receipt such report party shall confer agree whether reconciliation payment from party other amount such reconciliation payment that party share phase cost accordance with section nbsp party required such reconciliation payment shall other party such payment within after such period style margin margin bottom text indent font size font family time roman servier responsible hundred percent nbsp phase cost forth section nbsp then within after each calendar quarter which party conducting phase clinical trial licensed product miragen shall submit servier reasonably detailed invoice setting forth phase cost incurred miragen such calendar quarter servier shall miragen amount invoiced within after receipt invoice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman miragen required reimburse servier phase cost forth section nbsp then within after each calendar quarter which party conducting phase clinical trial licensed product date upon which miragen enters into partner agreement date upon which miragen file licensed product applicable servier shall submit miragen reasonably detailed invoice setting forth phase cost incurred servier such calendar quarter before such date applicable miragen shall servier amount invoiced within after receipt invoice style margin margin bottom text indent font size font family time roman unsponsored work party desire data resulting from unsponsored work conducted other party related regulatory material purpose other than comply with regulatory reporting requirement territory such party shall notify other party writing within after receipt such notice other party shall submit such party reasonable detailed invoice setting forth unsponsored work development cost incurred such other party course conducting development work that generated such data party seeking such data desire such data such other purpose after reimbursing such cost such party shall notify other party writing shall other party amount invoiced within after receipt invoice style margin margin bottom text indent font size font family time roman companion diagnostic development cost style margin margin bottom text indent font size font family time roman within after each calendar quarter during which party developing companion diagnostic miragen shall submit servier reasonably detailed invoice setting forth companion diagnostic development cost incurred miragen such calendar quarter servier shall miragen amount invoiced within after receipt invoice style margin margin bottom text indent font size font family time roman after nbsp miragen entered into agreement with third party grant such third party right import offer sale sale such companion diagnostic outside territory forth section nbsp nbsp miragen entered into partner agreement licensed product associated with such companion diagnostic forth section nbsp nbsp receipt notice from miragen that miragen will reimburse servier part companion diagnostic development cost companion diagnostic forth section nbsp nbsp date upon which miragen file regulatory approval application companion diagnostic whichever earlier servier shall submit miragen reasonably detailed invoice setting forth companion diagnostic development cost such companion diagnostic incurred servier prior such date thereafter applicable within after each calendar quarter during which party developing such companion diagnostic servier shall submit miragen reasonably detailed invoice setting forth companion diagnostic development cost such companion diagnostic incurred servier such calendar quarter miragen shall servier amount invoiced within after receipt invoice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman milestone payment style margin margin bottom text indent font size font family time roman designation third target servier shall miragen time refundable creditable payment three million euro nbsp after selection third target that successfully passed gate keeping been accepted santaris pursuant section nbsp such payment shall made within after receipt invoice provided however that amount this payment shall third target third target that style margin margin bottom text indent font size font family time roman each three nbsp target servier shall miragen refundable creditable payment after first licensed product that modulates such target which shall notified servier miragen within after within after receipt invoice which amount shall nbsp nbsp target that first achieves such milestone such target member either microrna target family microrna target family nbsp target that first achieves such milestone member microrna target family microrna target family nbsp each second third target that achieve such milestone style margin margin bottom text indent font size font family time roman other development milestone style margin margin bottom text indent font size font family time roman subject section nbsp last sentence section nbsp below each three nbsp target servier shall miragen refundable creditable payment forth below each case after milestone such target first achieved licensed product directed such target which shall notified servier miragen within after such achievement within after receipt invoice style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp nbsp valign bottom align center style border bottom solid bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman event that milestone forth section nbsp achieved with respect particular target major indication after such milestone already been achieved with respect such target orphan indication then upon achievement such milestone such major indication servier shall miragen difference between applicable milestone payment such major indication milestone payment already paid such target such orphan indication event that milestone achieved with respect particular target major indication after such milestone already been achieved with respect such target orphan indication style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman major indication then upon achievement such milestone such major indication servier shall miragen difference between applicable milestone payment such major indication milestone payment already paid such target such orphan indication major indication applicable determination whether indication major indication shall made shall discus such determination provided event that particular indication major indication made milestone payment miragen based upon such determination such indication subsequently demonstrated have annual peak sale territory least then with respect each such milestone payment servier shall promptly miragen difference between applicable milestone payment such major indication milestone payment already paid miragen major indication rate style margin margin bottom text indent font size font family time roman commercial milestone style margin margin bottom text indent font size font family time roman each three nbsp target servier shall miragen refundable creditable payment within after calendar quarter during which aggregated annual sale licensed product directed such target across territory indication exclusion orphan indication first equal exceed which amount shall equal clarity upon payment servier amount forth this section nbsp further amount shall servier pursuant section above with respect such target except applicable orphan indication style margin margin bottom text indent font size font family time roman addition payment forth section nbsp servier shall miragen time refundable creditable payment forth below each case within after calendar quarter during which aggregated annual sale licensed product territory first reach value indicated below clarity milestone payment this section nbsp shall additive such that more than milestone specified below achieved same calendar quarter different calendar quarter then milestone payment such milestone shall payable style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman annual sale licensed product territory valign bottom nbsp nbsp valign bottom align center style border bottom solid payment bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman equal exceed valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman equal exceed valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman equal exceed valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman royalty payment licensed product style margin margin bottom text indent font size font family time roman royalty rate subject other term this section nbsp during royalty term servier shall make quarterly refundable creditable royalty payment miragen sale each licensed product sold territory licensed product licensed product country country basis applicable royalty rate forth below style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman purpose this section daily cost treatment particular licensed product particular country mean average sale unit such licensed product such country specific calendar quarter converted euro divided number between each such licensed product specified label such licensed product such country unit sale divided licensed product labeled administered once month style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman daily cost treatment valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman than equal valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman greater than than equal valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman greater than than equal valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman greater than valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman royalty term each licensed product licensed product licensed product country country basis servier royalty payment obligation under this section nbsp shall commence upon first commercial sale such licensed product such country expire upon later nbsp included miragen patent such country claiming licensed product manufacture which being sold used such country nbsp anniversary first commercial sale such licensed product such country provided however that servier payment obligation under this section nbsp with respect royalty increase provided section nbsp with respect license acquiror shall expire licensed product licensed product country country basis upon expiration last expire valid claim included acquiror that claim licensed product manufacture which being sold used such country style margin margin bottom text indent font size font family time roman royalty reduction style margin margin bottom text indent font size font family time roman licensed product generating sale country territory during royalty term such country time when sale manufacture field such licensed product covered valid claim included miragen patent including miragen patent such country which servier license under this agreement have been terminated pursuant section nbsp such country then royalty rate applicable sale such licensed product such country shall reduced royalty rate forth section nbsp style margin margin bottom text indent font size font family time roman time following first commercial sale country where licensed product covered valid claim included miragen patent licensed servier such country nbsp several generic competitor such licensed product sold such calendar quarter represent unit basis more unit licensed product sold that country that quarter then royalty rate applicable sale such licensed product such country such calendar quarter shall reduced style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman royalty rate that would otherwise applicable such licensed product such country nbsp several generic competitor such licensed product sold such calendar quarter represent unit basis more unit licensed product sold that country such calendar quarter then royalty rate applicable sale such licensed product such country such calendar quarter shall reduced royalty rate that would otherwise applicable such licensed product such country royalty reduction provided this section nbsp shall only remain effect long generic competitor exceeds market share threshold forth above relevant calendar quarter style margin margin bottom text indent font size font family time roman necessary servier obtain license from third party under patent right country territory nbsp order manufacture import sell licensed product nbsp order have exclusive right manufacture import sell licensed product event servier owner patent right with third party servier obtains such license servier shall have right deduct from royalty payment that would otherwise have been with respect sale such licensed product such country particular calendar quarter amount equal royalty paid servier such third party pursuant such license account sale such licensed product such country during such calendar quarter provided however that event shall royalty payable miragen reduced more than calendar quarter operation this section nbsp style margin margin bottom text indent font size font family time roman licensed product licensed product country country calendar quarter calendar quarter basis cost good average unit such licensed product sold such country exceeds percentage forth table below sale such average unit such licensed product such country then then applicable royalty rate shall reduced with respect sale such licensed product such country during such calendar quarter applicable royalty offset forth table below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman cost good finished product unit percentage sale unit valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp offset bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman greater than than equal valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman greater than than equal valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman greater than valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman servier shall entitled reduce royalty payable miragen account sale licensed product territory other reason event shall royalty payable miragen than nbsp total payment owed miragen third party account such sale plus only section applicable such sale nbsp total payment owed miragen third party account such sale plus more than section applicable such sale provided however that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman application nbsp nbsp above shall result servier having more royalty than application initial royalty rate forth section nbsp without application section nbsp factor affecting profitability licensed product territory change materially during term party shall meet discus good faith possible modification royalty payment licensed product territory light such changed factor provided however that disagreement with respect such modification shall subject dispute resolution mechanism forth section nbsp style margin margin bottom text indent font size font family time roman royalty report payment within after each calendar quarter commencing with calendar quarter during which first commercial sale licensed product made anywhere territory servier shall provide miragen with report that contains following information applicable calendar quarter licensed product licensed product country country basis nbsp amount gross sale licensed product territory nbsp itemized calculation sale territory showing deduction provided definition sale nbsp calculation royalty payment such sale including application reduction adjustment made accordance with section nbsp nbsp exchange rate such country within fifteen delivery applicable quarterly report servier shall euro royalty miragen with respect sale servier affiliate their respective sublicensees such calendar quarter style margin margin bottom text indent font size font family time roman currency exchange rate amount payable hereunder shall euro bank wire transfer immediately available fund bank account designated written notice from party that receives payment calculation relating sale royalty hereunder shall euro applicable sale shall translated from other currency into euro using monthly average daily rate exchange published european central bank monthly period which sale accounted style margin margin bottom text indent font size font family time roman late payment either party receive payment before date therefor simple interest shall thereafter accrue daily basis such party from date until date payment rate equal euribor plus annum maximum rate allowable applicable whichever style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman income each party shall solely responsible payment imposed share income arising directly indirectly from collaborative effort party under this agreement style margin margin bottom text indent font size font family time roman cooperation party agree cooperate with another reasonable commercial effort accordance with applicable reduce eliminate extent possible withholding similar obligation payment made under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman withholding common understanding party that effective date none payment payable under this agreement subject deduction withholding account application treaty force between france united state since august nbsp accordance with amendment signed january nbsp which came into force retroactively january nbsp payment payable under this agreement will made without deduction withholding account unless such deduction withholding required applicable paying party required deduct withhold such party shall nbsp promptly notify other party such requirement nbsp relevant authority full amount required deducted withheld promptly upon earlier determining that such deduction withholding required receiving notice that such amount been assessed against other party nbsp promptly forward other party official receipt certified copy other documentation reasonably acceptable other party evidencing such payment such authority style margin margin bottom text indent font size font family time roman resulting from servier action result action taken servier servier affiliate successor including assignment transfer portion this agreement permitted under section nbsp failure servier servier affiliate successor such action failure servier withholding action amount that servier required deduct withhold from payment made servier miragen under this agreement increased then payable servier miragen shall increased extent necessary ensure that miragen receives equal that miragen would have received such servier withholding action occurred style margin margin bottom text indent font size font family time roman record audit right each party shall maintain complete accurate record sufficient detail permit other party confirm accuracy amount research development plan cost reimbursed shared achievement sale milestone royalty payment other amount payable under this agreement upon reasonable prior notice such record shall open during regular business hour period year from creation individual record examination auditing party expense more often than once each calendar year independent certified public accountant selected auditing party reasonably acceptable audited party sole purpose verifying auditing party accuracy financial report furnished audited party pursuant this agreement payment made required made audited party pursuant this agreement such auditor shall disclose audited party confidential information auditing party except extent such disclosure necessary verify accuracy financial report furnished audited party amount payment audited party under this agreement amount shown owed unpaid overpaid need reimbursement shall paid refunded case within after accountant report plus interest forth section nbsp from original date unless challenged good faith audited party which case dispute with respect thereto shall resolved accordance with section nbsp auditing party shall bear full cost such audit unless such audit reveals overpayment underpayment audited party that resulted from discrepancy financial report provided audited party audited period which underpayment overpayment more than amount forth such report which case audited party shall reimburse auditing party cost such audit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property right style margin margin bottom text indent font size font family time roman ownership invention disclosure ownership invention shall assigned based inventorship determined accordance with rule inventorship under united state patent except that party shall jointly invention first developed pursuant research plan whether such invention made solely party jointly party jointly owned invention shall referred joint each party shall undivided half interest joint without duty accounting obligation seek consent from other party exploitation license joint subject license granted other party under this agreement restriction forth section nbsp know included joint shall referred joint know patent right included joint shall referred joint patent promptly after making invention inventing party shall provide other party with complete written disclosure such invention style margin margin bottom text indent font size font family time roman patent prosecution style margin margin bottom text indent font size font family time roman miragen sole patent style margin margin bottom text indent font size font family time roman between party miragen shall responsible filing prosecuting maintaining miragen patent that joint patent miragen sole patent servier shall responsible shall reimburse miragen reasonable cost expense filing prosecuting maintaining miragen sole patent territory miragen shall responsible cost expense filing prosecuting maintaining miragen sole patent outside territory miragen shall consult with servier keep servier reasonably informed status miragen sole patent territory shall promptly provide servier with material correspondence received from patent authority connection therewith addition miragen shall promptly provide servier with draft proposed material filing correspondence patent authority with respect miragen sole patent territory servier review comment prior submission such proposed filing correspondence miragen shall confer with servier take into consideration servier comment prior submitting such filing correspondence provided that servier shall provide such comment within nbsp month receiving draft filing correspondence from miragen servier provide comment within such period time then servier shall deemed have comment such proposed filing correspondence case disagreement between party with respect filing prosecution maintenance such miragen sole patent final decision shall made miragen purpose this article prosecution shall include post grant proceeding including patent interference proceeding opposition proceeding reexamination style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman miragen shall notify servier decision cease prosecution maintenance miragen sole patent territory miragen shall provide such notice least sixty nbsp prior filing payment date other date that requires action connection with such miragen sole patent such event miragen shall permit servier discretion expense continue prosecution maintenance such miragen sole patent license granted servier under this agreement with respect such miragen sole patent shall royalty free servier prosecution maintenance such miragen sole patent shall change party respective right obligation under this agreement with respect such miragen sole patent other than those expressly forth this section nbsp style margin margin bottom text indent font size font family time roman servier shall notify miragen decision continue expense prosecution maintenance miragen sole patent territory servier shall provide such notice least sixty nbsp prior payment date connection with such miragen sole patent such event license granted servier under this agreement with respect such miragen sole patent shall terminated style margin margin bottom text indent font size font family time roman joint patent style margin margin bottom text indent font size font family time roman each party shall responsible filing prosecuting maintaining joint patent territory cost expense each party shall fully cooperate with other party connection with filing prosecution maintenance such joint patent such other party territory responsible party particular territory shall consult with other party shall keep other party reasonably informed status such joint patent shall promptly provide other party with draft proposed material filing correspondence with patent authority with respect such joint patent such other party review comment prior submission such proposed filing correspondence responsible party shall confer with other party take into consideration such other party comment prior submitting such filing correspondence provided that such other party shall provide such comment within nbsp month receiving draft filing correspondence from responsible party such other party provide comment within such period time then such other party shall deemed have comment such proposed filing correspondence case disagreement between party with respect filing prosecution maintenance such joint patent final decision shall made responsible party notwithstanding foregoing party shall confer reach agreement prior filing priority patent application joint whether such filing territory outside territory style margin margin bottom text indent font size font family time roman responsible party shall notify other party decision cease prosecution maintenance continue expense prosecution maintenance joint patent responsible party shall provide such notice least sixty nbsp prior filing payment date other date that requires action connection with such joint patent such event such other party request responsible party shall assign such other party free charge right such joint patent worldwide such joint patent shall thereafter fall scope this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman event that this agreement terminates miragen obtains exclusive license under joint pursuant section nbsp then miragen shall have right obligation elect prosecute maintain joint patent that exclusively licensed miragen throughout world miragen cost expense extent that such joint patent includes both claim that exclusively licensed miragen other claim miragen shall commercially reasonable effort file divisional application such joint patent separate these claim allow section continue apply claim that exclusively licensed miragen style margin margin bottom text indent font size font family time roman servier sole patent style margin margin bottom text indent font size font family time roman between party servier shall responsible filing prosecuting maintaining servier patent that joint patent servier sole patent miragen shall responsible shall reimburse servier reasonable cost expense filing prosecuting maintaining servier sole patent outside territory servier shall responsible cost expense filing prosecuting maintaining servier sole patent territory servier shall consult with miragen keep miragen reasonably informed status servier sole patent outside territory shall promptly provide miragen with material correspondence received from patent authority addition servier shall promptly provide miragen with draft proposed material filing correspondence patent authority with respect servier sole patent miragen review comment prior submission such proposed filing correspondence servier shall confer with miragen take into consideration miragen comment prior submitting such filing correspondence provided that miragen shall provide such comment within nbsp month receiving draft filing correspondence from servier miragen provide comment within such period time then miragen shall deemed have comment such proposed filing correspondence case disagreement between party with respect filing prosecution maintenance servier sole patent final decision shall made servier style margin margin bottom text indent font size font family time roman servier shall notify miragen decision cease prosecution maintenance prosecution maintenance servier sole patent outside territory servier shall provide such notice least sixty nbsp prior filing payment date other date that requires action connection with such servier sole patent such event servier shall permit miragen discretion expense continue prosecution maintenance such servier sole patent miragen prosecution maintenance such servier sole patent shall change party respective right obligation under this agreement with respect such servier sole patent other than expressly forth this section nbsp style margin margin bottom text indent font size font family time roman miragen shall notify servier decision continue expense prosecution maintenance servier sole patent outside territory miragen shall provide such notice least sixty nbsp prior payment date connection with such servier sole patent such event license granted miragen under this agreement with respect such servier sole patent shall terminated style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman patent enforcement style margin margin bottom text indent font size font family time roman each party shall notify other within fifteen nbsp business becoming aware alleged threatened infringement third party miragen patent servier patent which infringement adversely affect expected adversely affect licensed product companion diagnostic including patent certification filed united state under similar provision other jurisdiction declaratory judgment opposition similar action alleging invalidity unenforceability infringement miragen patent servier patent collectively product infringement style margin margin bottom text indent font size font family time roman servier shall have first right bring control legal action connection with such product infringement territory expense reasonably determines appropriate miragen shall have right represented such action counsel choice servier decides bring such legal action shall inform miragen promptly miragen shall have right bring control legal action connection with such product infringement territory expense reasonably determines appropriate after consultation with servier unless servier reasonably object such action likely having material adverse effect upon commercialization including profitability licensed product territory style margin margin bottom text indent font size font family time roman miragen shall have exclusive right bring control legal action connection with such product infringement outside territory expense reasonably determines appropriate miragen shall have exclusive right enforce miragen patent other than joint patent infringement that product infringement expense reasonably determines appropriate servier shall have exclusive right enforce servier patent other than joint patent infringement that product infringement expense reasonably determines appropriate each party shall have first right territory enforce joint patent infringement that product infringement expense reasonably determines appropriate such party decides bring such legal action shall inform other party promptly other party shall have right bring control legal action connection with such infringement expense reasonably determines appropriate after consultation with party having first right enforce unless party having first right enforce reasonably object such action likely having material adverse effect upon activity territory style margin margin bottom text indent font size font family time roman request party bringing action other party shall provide reasonable assistance connection therewith including executing reasonably appropriate document cooperating discovery joining party action required style margin margin bottom text indent font size font family time roman connection with such proceeding party bringing action shall enter into settlement admitting invalidity infringement otherwise impairing other party right miragen patent servier patent without prior written consent other party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman recovery resulting from enforcement action relating claim product infringement territory shall first applied against payment each party cost expense connection therewith such recovery excess such cost expense remainder shall recovery resulting from enforcement action relating claim product infringement outside territory shall retained miragen style margin margin bottom text indent font size font family time roman trademark servier shall have right brand licensed product using servier related trademark other trademark trade name determines appropriate licensed product which vary country within country product mark servier shall right product mark territory shall register maintain product mark country region territory that determines reasonably necessary servier cost expense style margin margin bottom text indent font size font family time roman patent extension style margin margin bottom text indent font size font family time roman party shall cooperate obtaining patent term restoration under limited drug price competition patent term restoration supplemental protection certificate their equivalent patent term extension with respect miragen patent servier patent country region where applicable style margin margin bottom text indent font size font family time roman shall determine which miragen patent shall apply extend territory servier shall file such extension servier cost expense servier reasonable request miragen shall provide reasonable assistance servier connection with such filing style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center confidentiality publication style margin margin bottom text indent font size font family time roman duty confidence subject other provision this article style margin margin bottom text indent font size font family time roman confidential information disclosed party disclosing party affiliate under this agreement shall maintained confidence otherwise safeguarded recipient party receiving party affiliate same manner with same protection such receiving party maintains confidential information clarity miragen know servier know shall deemed confidential information both party with each party having obligation receiving party forth this article having right exempted from such obligation account section nbsp style margin margin bottom text indent font size font family time roman receiving party only such confidential information purpose performing obligation exercising right under this agreement style margin margin bottom text indent font size font family time roman receiving party disclose confidential information other party nbsp affiliate sublicensees nbsp employee director agent contractor consultant adviser receiving party affiliate sublicensees each case extent reasonably necessary purpose those matter undertaken pursuant this agreement provided that such person bound maintain confidentiality confidential information manner consistent with confidentiality provision this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman confidentiality obligation forth herein shall remain force during term period year thereafter except that servier confidentiality obligation nbsp with respect miragen confidential information that confidential information santaris defined santaris agreement shall remain force indefinitely except extent that such information disclosed santaris pursuant confidentiality agreement among santaris miragen servier dated june nbsp three servier confidentiality obligation pursuant three have expired nbsp with respect miragen confidential information that confidential information university north carolina chapel hill university texas system defined agreement southwestern agreement applicable shall remain force during term agreement southwestern agreement applicable period year thereafter style margin margin bottom text indent font size font family time roman exception foregoing obligation particular confidential information disclosing party shall apply extent that receiving party demonstrate that such confidential information style margin margin bottom text indent font size font family time roman known receiving party time receipt without obligation confidentiality through prior disclosure disclosing party documented receiving party business record style margin margin bottom text indent font size font family time roman public domain before receipt from disclosing party thereafter enters public domain through fault receiving party style margin margin bottom text indent font size font family time roman subsequently disclosed receiving party third party lawfully under obligation confidentiality disclosing party style margin margin bottom text indent font size font family time roman developed receiving party independently without reference confidential information received from disclosing party documented receiving party business record style margin margin bottom font size font family time roman combination feature disclosure shall deemed fall within foregoing exclusion merely because individual feature published available general public rightful possession receiving party unless combination itself principle operation published available general public rightful possession receiving party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman authorized disclosure notwithstanding obligation forth section nbsp party disclose other party confidential information including this agreement term herein extent style margin margin bottom text indent font size font family time roman such disclosure nbsp reasonably necessary filing prosecuting patent right contemplated this agreement nbsp reasonably necessary connection with regulatory filing licensed product nbsp reasonably necessary prosecuting defending litigation contemplated this agreement nbsp made third party bound written obligation confidentiality similar those forth under this article extent otherwise necessary appropriate connection with exercise right performance obligation hereunder style margin margin bottom text indent font size font family time roman such disclosure reasonably necessary nbsp such party director attorney independent accountant financial advisor sole purpose enabling such director attorney independent accountant financial advisor provide advice such party provided that each such case condition that such director attorney independent accountant financial advisor bound confidentiality obligation substantially consistent with those contained this agreement provided however that term confidentiality such director attorney independent accountant financial advisor shall than year from disclosure nbsp bona fide actual potential investor acquirors licensee other financial commercial partner solely purpose evaluating actual potential investment acquisition collaboration provided that nbsp each such case condition that such actual potential partner bound confidentiality obligation substantially consistent with those contained agreement provided however that term confidentiality such partner shall than year from disclosure nbsp miragen shall provide servier with list bona fide potential partner before making first such confidential disclosure such potential partner servier shall have right select from such list nbsp potential partner which miragen make such disclosure style margin margin bottom text indent font size font family time roman such disclosure required judicial administrative process provided that such event such party shall promptly inform other party such required disclosure provide other party opportunity challenge limit disclosure obligation confidential information that disclosed judicial administrative process shall remain otherwise subject confidentiality provision this article party disclosing confidential information pursuant court order shall take step reasonably necessary including seeking confidential treatment protective order ensure continued confidential treatment such confidential information style margin margin bottom text indent font size font family time roman scientific publication publication strategy shall managed jrdc which shall have right review approve scientific publication considering servier miragen interest publishing result research development work order obtain recognition within scientific community advance state scientific knowledge need protect confidential information party mutual interest obtaining valid patent protection protecting reasonable business interest trade secret information having integrated approach developing more licensed product more indication consequently except disclosure permitted pursuant section nbsp each party their affiliate employee consultant shall deliver jrdc review comment copy proposed publication presentation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman that pertains licensed oligo licensed product pursuant procedure established jrdc jrdc shall have right require modification publication presentation nbsp protect each party respective confidential information nbsp trade secret reason business reason nbsp delay such submission additional reasonably necessary seek patent protection information disclosed such proposed submission case disagreement jrdc level party receiving proposal publication presentation shall have final style margin margin bottom text indent font size font family time roman publicity name servier miragen have agreed language joint press release announcing this agreement which attached hereto exhibit nbsp issued party promptly after mutual execution agreement subject section nbsp above other disclosure existence term this agreement made either party affiliate except provided this section nbsp required applicable party shall name trademark trade name logo other party affiliate their respective employee publicity promotion news release disclosure relating this agreement subject matter except provided this section nbsp with prior express written permission other party except required applicable style margin margin bottom text indent font size font family time roman party disclose this agreement term material development material information generated under this agreement security filing with security exchange commission equivalent foreign agency extent required applicable after complying with procedure forth this section nbsp such event party seeking such disclosure shall prepare draft confidential treatment request proposed redacted version this agreement request confidential treatment this agreement other party agrees promptly event than seven nbsp after receipt such confidential treatment request proposed redaction give input reasonable manner order allow party seeking disclosure file request within time line proscribed applicable party seeking such disclosure shall exercise commercially reasonable effort obtain confidential treatment agreement from security exchange commission equivalent foreign agency represented redacted version reviewed other party style margin margin bottom text indent font size font family time roman further each party acknowledges that other party legally required make public disclosure including filing with government authority certain material development material information generated under this agreement agrees that each party make such disclosure required provided that party seeking such disclosure first provides other party copy proposed disclosure provided further that except extent that party seeking disclosure required disclose such information comply with applicable other party demonstrates reasonable satisfaction party seeking disclosure within nbsp such party providing copy that public disclosure previously undisclosed information shall materially adversely affect development commercialization licensed oligo licensed product being developed commercialized under this agreement party seeking disclosure shall remove from disclosure such specific previously undisclosed information other party shall reasonably request removed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman other than press release forth exhibit party agree that other news release other public announcement relating this agreement performance hereunder that would disclose information other than that already public domain shall first reviewed approved both party with such approval unreasonably withheld delayed provided however that notwithstanding foregoing miragen shall have right disclose publicly including website nbsp fact that entered into this agreement nbsp commencement result each clinical trial conducted party under this agreement nbsp receipt milestone payment under this agreement nbsp regulatory approval licensed product nbsp first commercial sale licensed product nbsp royalty received from servier without disclosing royalty rate sale reported servier each such disclosure unless miragen otherwise right make such disclosure under this article miragen shall provide servier with draft such disclosure least five nbsp business prior intended release servier review comment shall consider servier comment good faith miragen receive comment from servier within five nbsp business miragen shall have right make such disclosure without further delay style margin margin bottom text indent font size font family time roman party agree that after disclosure pursuant section nbsp press release including initial press release other public announcement pursuant section nbsp been reviewed approved other party disclosing party make subsequent public disclosure reiterating such information without alteration entirety without having obtain other party prior consent approval style margin margin bottom text indent font size font family time roman each party agrees that other party shall have right such first party name logo presentation company website collateral material corporate overview describe collaboration relationship well taglines press release issued pursuant this section nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom text indent font size font family time roman term term this agreement shall commence upon effective date continue full force effect licensed product licensed product basis until expiration royalty obligation servier with respect applicable licensed product unless earlier terminated forth section nbsp below term style margin margin bottom text indent font size font family time roman termination style margin margin bottom text indent font size font family time roman termination servier convenience time servier terminate this agreement either entirety target target country country basis providing written notice termination miragen which notice includes effective date termination least after date notice provided that this agreement been terminated major market country including prior termination this agreement major market country pursuant this section nbsp then this agreement shall deemed have been terminated with respect country across territory target target basis style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman termination servier safety public health reason notwithstanding section nbsp servier reasonably determines that safety public health issue arisen which demonstrated clinically relevant event which documented which relate least licensed product directed particular target shall immediately notify miragen shall permitted terminate agreement with respect such target providing written notice termination miragen which termination with respect territory entirety with respect country outside only country country basis which termination shall effective nbsp with respect target related activity research plan after miragen receipt termination notice nbsp with respect other target related activity under development plan with respect unsponsored work being conducted behalf servier after miragen receipt termination notice promptly after miragen receipt servier notice pursuant this section nbsp shall hold special meeting discus clinically relevant event that basis servier termination pursuant this section nbsp style margin margin bottom text indent font size font family time roman termination material breach either party belief that other breach material obligation hereunder then breaching party deliver notice such breach other party which notice shall clearly mention remedy that breaching party intends apply should breach remain uncured allegedly breaching party shall have from such notice dispute cure such breach party receiving notice breach fails cure such breach fails dispute matter described next sentence within such period then nbsp party originally delivering notice servier then servier either nbsp terminate this agreement entirety target target country country basis with being considered single country provided however that servier opts termination target target country country basis such termination shall only possible country target which such breach relates effective written notice termination miragen nbsp proceed under section nbsp written notice miragen specifying servier intent proceed under section nbsp nbsp party originally delivering notice miragen either nbsp servier uncured material breach nbsp servier uncured material breach nbsp then miragen terminate this agreement entirety target target country country basis with being considered single country provided however that miragen opts termination target target country country basis such termination shall only possible country target which such breach relates effective written notice termination servier allegedly breaching party good faith dispute such material breach dispute failure cure remedy such material breach servier allegedly breaching party material breach dispute whether provides written notice that dispute other party within applicable period forth above matter shall addressed under dispute resolution provision section nbsp notifying party terminate this agreement until been determined under section nbsp that nbsp allegedly breaching party material breach this agreement nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman servier breaching party material breach that such breaching party further fails cure such breach within after conclusion that dispute resolution procedure such dispute concerning existence such material breach such termination shall then effective upon written notification from notifying party breaching party servier uncured material breach arbitrator under section nbsp decides that under this agreement reason reason then servier elect within thirty nbsp after arbitrator decision with respect which case deciding whether arbitrator shall consider including whether whether whether whether whether notwithstanding above except dispute mechanism breach obligation then terminate agreement provided however that terminate this agreement forth section either forth above dispute mechanism account such breach sake clarity shall have right terminate this agreement account breach obligation style margin margin bottom text indent font size font family time roman termination patent challenge except extent nbsp following nbsp unenforceable under particular jurisdiction miragen terminate this agreement entirety servier affiliate sublicensees individually association with other person entity commences legal action challenging validity enforceability scope miragen patent servier terminate this agreement entirety miragen affiliate sublicensees individually association with other person entity commences legal action challenging validity enforceability scope servier patent style margin margin bottom text indent font size font family time roman effect termination style margin margin bottom text indent font size font family time roman upon earlier termination this agreement reason license other right granted servier under miragen therapeutic miragen companion diagnostic shall terminate provided that such termination shall limited terminated target terminated country event that this agreement terminated only particular target particular country unless otherwise provided this section nbsp license other right granted miragen under servier therapeutic servier companion diagnostic shall terminate provided that such termination shall limited terminated target shall only apply event that this agreement terminated such target country across territory style margin margin bottom text indent font size font family time roman following consequence shall apply miragen written request only event termination servier pursuant section nbsp miragen pursuant section nbsp provided however event termination only particular target particular country such consequence shall limited licensed oligos licensed product terminated target terminated country companion diagnostics connection with licensed product terminated target terminated country applicable style margin margin bottom text indent font size font family time roman miragen license license other right granted miragen under servier therapeutic servier companion diagnostic shall survive style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman addition servier hereby grant miragen effective only upon such termination exclusive royalty bearing sublicenseable through multiple tier license under servier therapeutic develop make have made import offer sale sell licensed oligos licensed product terminated target terminated country nbsp exclusive fully paid except payment made servier third party which case against reimbursement corresponding amount sublicenseable through multiple tier license under servier companion diagnostic develop make have made import offer sale sell companion diagnostics connection with licensed product terminated target terminated country style margin margin bottom text indent font size font family time roman joint servier hereby grant miragen effective upon termination this agreement royalty bearing exclusive sublicenseable through multiple tier license under servier interest joint develop make have made import offer sale sell licensed oligos licensed product terminated target terminated country companion diagnostics connection with licensed product terminated target terminated country style margin margin bottom text indent font size font family time roman regulatory material data servier shall transfer assign miragen cost miragen other than specified section nbsp regulatory material regulatory approval licensed product data from clinical clinical study conducted behalf servier affiliate sublicensees licensed product pharmacovigilance data including adverse event database licensed product regulatory material regulatory approval companion diagnostics data generated behalf servier affiliate sublicensee development companion diagnostics each case terminated target terminated country style margin margin bottom text indent font size font family time roman transition assistance style margin margin bottom text indent font size font family time roman this agreement terminated with respect target country territory servier shall promptly return miragen know data material other confidential information transferred miragen servier under this agreement style margin margin bottom text indent font size font family time roman time such termination servier supplying licensed oligos licensed product terminated target miragen servier terminated country servier shall assist miragen establishing alternative supplier such licensed oligos licensed product shall supply such licensed oligos licensed product miragen same financial condition under which servier supplying miragen prior termination servier cost servier supplying itself prior termination until miragen established alternative supplier provided such obligation shall under circumstance lead servier having supply miragen with licensed product licensed oligos nbsp human nbsp termination reason safety style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman upon miragen request servier shall servier choice assign sublicense miragen license agreement where servier affiliate licensor where servier affiliate granted license intellectual property that servier therapeutic with respect licensed product field territory agreement arrangement with third party vendor that specific necessary development manufacture commercialization licensed product field territory provided that nbsp such provision shall only apply respect terminated country terminated target nbsp miragen shall reimburse servier reasonable cost borne servier satisfy such obligation which cost shall subject miragen prior review approval unreasonably withheld nbsp servier entitled without breaching obligation have with third party style margin margin bottom text indent font size font family time roman servier shall miragen request provide reasonable technical assistance transfer servier know relating licensed oligos licensed product terminated target miragen designee style margin margin bottom text indent font size font family time roman time such termination servier conducting clinical trial licensed product terminated target terminated country then miragen election trial trial basis nbsp servier shall fully cooperate with miragen transfer conduct such clinical trial miragen miragen shall assume liability cost such clinical trial after effective date such termination provided that event this agreement terminated miragen under section nbsp servier shall continue bear cost expense incurred connection with such clinical trial until earlier completion such trial after effective date such termination nbsp servier shall expense orderly wind down conduct such clinical trial which assumed miragen under clause each case servier contracting party third party agreement relating such clinical trial servier shall reimburse miragen cancellable refundable pocket cost miragen incur under such third party agreement connection with conduct wind down such clinical trial such cost were incurred prior effective date such termination style margin margin bottom text indent font size font family time roman this agreement terminated servier under section nbsp miragen under section nbsp servier shall responsible cancelable refundable pocket cost already committed miragen pursuant research plan development plan miragen shall reasonable effort limit much possible commitment term cancelable refundable pocket cost while entering into agreement with third party style margin margin bottom text indent font size font family time roman financial condition liability consideration nbsp above miragen shall style margin margin bottom text indent font size font family time roman reimburse servier quarterly basis with first payment only payable month after effective date termination post termination cost borne servier relation transfer miragen regulatory material regulatory approval clinical clinical data transition assistance except cost that servier responsible under section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman except event described section nbsp below event that this agreement terminated several particular target entirety country across territory data provided servier were used being used filing licensed product such terminated target reimburse servier development cost extent already reimbursed prior effective date termination incurred servier development activity that generated data used such filing clarity miragen shall only required make payment forth either this section nbsp section nbsp below both style margin margin bottom text indent font size font family time roman event that this agreement terminated miragen several particular target some country across territory including material breach servier commercial diligence commitment data provided servier were used being used filing licensed product such terminated target reimburse servier nbsp development cost data were used being used only only both nbsp development cost data were used being used both purpose this section nbsp development cost shall those incurred servier development activity that generated data used such filing shall reimbursed miragen extent already reimbursed prior effective date termination style margin margin bottom text indent font size font family time roman miragen data provided servier filing more terminated country outside territory licensed product obtained servier prior termination such terminated country outside territory make following quarterly refundable creditable royalty payment servier sale whose definition applies miragen mutatis mutandis licensed product terminated target such terminated country outside territory licensed product licensed product basis style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign such licensed product effective date termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign such licensed product effective date termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign such licensed product effective date termination table style margin margin bottom text indent font size font family time roman abovementioned royalty payment obligation shall expire licensed product licensed product country country basis upon later nbsp expiration last expire valid claim included servier patent such country claiming licensed product manufacture which being sold used such country nbsp tenth style font size vertical align nbsp anniversary first commercial sale whether servier miragen their respective affiliate sublicensees such licensed product such country combined royalty payment servier third party including upstream licensors licensed product make commercially reasonable commercialize such licensed product servier miragen shall negotiate good faith reasonable reduction royalty rate forth above this section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman provided that servier complies with procedure forth section nbsp hold servier affiliate fully indemnified harmless from against claim including limited product liability claim against them extent nbsp arising resulting from development commercialization licensed product terminated target terminated country miragen affiliate licensee sublicensees subcontractor after effective date termination nbsp arising from servier affiliate breach covenant representation warranty this agreement gross negligence willful misconduct servier affiliate style margin margin bottom text indent font size font family time roman survival expiration termination this agreement shall relieve party obligation accruing prior such expiration termination without limiting foregoing provision article nbsp section nbsp fourth sentence only shall survive expiration termination this agreement style margin margin bottom text indent font size font family time roman termination sole remedy termination sole remedy under this agreement whether termination effected notwithstanding anything contained this agreement contrary other remedy shall remain available except agreed otherwise herein style margin margin bottom text indent font size font family time roman alternative remedy miragen uncured material breach servier right proceed under this section nbsp notifies miragen pursuant section nbsp that exercising such right then this agreement shall stay full force effect with following modification commencing upon servier initiation arbitration pursuant section nbsp obtain damage account miragen uncured material breach that invocation this section nbsp continuing until issuance decision such arbitration provided that servier diligently pursues issuance decision such arbitration servier upon issuance decision such arbitration then miragen shall then servier shall obligation specified section shall unless otherwise decided arbitrator style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty style margin margin bottom text indent font size font family time roman representation warranty each party each party represents warrant other party execution date effective date that style margin margin bottom text indent font size font family time roman full right power authority enter into this agreement perform obligation hereunder style margin margin bottom text indent font size font family time roman this agreement been duly executed legally binding upon enforceable accordance with term conflict with agreement instrument understanding oral written which party which bound violate material regulation court governmental body administrative other agency having jurisdiction over style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman representation warranty miragen miragen represents warrant servier that except forth exhibit style margin margin bottom text indent font size font family time roman miragen affiliate knowledge effective date miragen patent patent controlled miragen affiliate effective date which reasonably necessary development manufacture importation sale licensed oligos licensed product field each case extent that licensed oligos licensed product pertain microrna microrna target family style margin margin bottom text indent font size font family time roman effective date neither affiliate miragen affiliate knowledge upstream licensors previously assigned transferred conveyed otherwise encumbered right title interest miragen therapeutic miragen companion diagnostic manner that inconsistent with license right granted servier under section nbsp style margin margin bottom text indent font size font family time roman right grant license right granted herein servier granted license right interest under miragen therapeutic miragen companion diagnostic third party affiliate that inconsistent with license right granted servier under section nbsp style margin margin bottom text indent font size font family time roman effective date neither affiliate miragen affiliate knowledge upstream licensors received written notice from third party asserting alleging that creation miragen therapeutic miragen companion diagnostic infringed misappropriated intellectual property right such third party style margin margin bottom text indent font size font family time roman miragen affiliate knowledge effective date conduct activity specified research plan attached hereto exhibit sample development plan attached hereto exhibit will infringe intellectual property right owned possessed third party effective date style margin margin bottom text indent font size font family time roman effective date there judgment settlement against owed miragen affiliate miragen affiliate knowledge effective date upstream licensors relating miragen therapeutic miragen companion diagnostic miragen affiliate knowledge there effective date pending threatened claim litigation relating miragen therapeutic miragen companion diagnostic style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman miragen covenant style margin margin bottom text indent font size font family time roman miragen shall maintain upstream license agreement force effect subject amendment permitted pursuant section nbsp until long intellectual property right licensed miragen under such upstream license agreement necessary conduct activity contemplated under this agreement including development manufacturing commercialization licensed product without infringing misappropriating intellectual property right upstream licensors event that upstream license agreement terminated upstream licensor miragen uncured material breach bankruptcy challenge licensed patent such termination arise directly indirectly from omission servier servier obtains from applicable upstream licensor direct license substitute servier sublicense from miragen under such upstream license agreement servier shall have right deduct from payment miragen hereunder amount paid servier under direct license such upstream licensor style margin margin bottom text indent font size font family time roman miragen shall prosecute maintain shall procure that affiliate upstream licensors case shall prosecute maintain miragen sole patent territory until either they held invalid unenforceable miragen notifies servier miragen decision cease prosecution maintenance miragen sole patent territory offer servier opportunity continue prosecution maintenance such miragen sole patent accordance with section nbsp style margin margin bottom text indent font size font family time roman miragen shall amend upstream license agreement without servier prior written consent except extent such amendment materially affect servier development manufacture commercialization licensed product create obligation servier miragen shall provide servier with copy proposed amendment upstream license agreement review comment prior entering into such amendment style margin margin bottom text indent font size font family time roman prior completion date miragen shall without servier prior written consent unless pursuant research plan development plan research development activity such case subject section style margin margin bottom text indent font size font family time roman prior completion date miragen shall without servier prior written consent unreasonably withheld delayed style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman representation warranty servier servier represents warrant miragen that style margin margin bottom text indent font size font family time roman servier affiliate knowledge effective date control patent which reasonably necessary useful development manufacture importation sale licensed oligos licensed product field each case extent that licensed oligos licensed product pertain microrna microrna target family style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman servier affiliate knowledge effective date conduct activity specified research plan attached hereto exhibit sample development plan attached hereto exhibit will infringe intellectual property right owned possessed third party effective date style margin margin bottom text indent font size font family time roman servier affiliate knowledge effective date right transfer servier sample miragen evaluation analysis pursuant research plan such transfer servier sample violate applicable conflict with agreement instrument understanding oral written which party which bound style margin margin bottom text indent font size font family time roman other warranty except expressly stated this article nbsp nbsp representation condition warranty whatsoever made given behalf servier miragen nbsp other condition warranty whether arising operation otherwise hereby expressly excluded including condition warranty merchantability fitness particular purpose infringement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification liability style margin margin bottom text indent font size font family time roman indemnification miragen miragen shall indemnify hold servier affiliate their respective officer director agent employee servier indemnitees harmless from against claim against them extent arising resulting from style margin margin bottom text indent font size font family time roman development licensed oligos companion diagnostics licensed product miragen affiliate licensee sublicensees subcontractor each case outside development plan style margin margin bottom text indent font size font family time roman commercialization licensed oligos companion diagnostic licensed product miragen affiliate licensee sublicensees subcontractor style margin margin bottom text indent font size font family time roman gross negligence willful misconduct miragen indemnitees style margin margin bottom text indent font size font family time roman breach warranty covenant representation made miragen servier under this agreement style margin margin bottom text indent font size font family time roman breach miragen material obligation pursuant this agreement style margin margin bottom text indent font size font family time roman except each case extent such claim result from material breach servier indemnitee covenant representation warranty other agreement made servier this agreement gross negligence willful misconduct servier indemnitee clarity miragen indemnification obligation pursuant this section nbsp will include claim brought santaris against servier account servier indemnification style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman obligation santaris arising from servier receipt sublicense under santaris agreement extent that such claim arise result from anything described subsection nbsp through nbsp above subject limitation forth this section nbsp with respect thereto style margin margin bottom text indent font size font family time roman indemnification servier servier shall indemnify hold miragen affiliate their respective officer director agent employee miragen indemnitees harmless from against claim arising under related this agreement against them extent arising resulting from style margin margin bottom text indent font size font family time roman development licensed oligos companion diagnostic licensed product servier affiliate sublicensees subcontractor each case outside development plan style margin margin bottom text indent font size font family time roman commercialization licensed oligos companion diagnostic licensed product servier affiliate sublicensees subcontractor style margin margin bottom text indent font size font family time roman gross negligence willful misconduct servier indemnitees style margin margin bottom text indent font size font family time roman breach warranty covenant representation made servier miragen under this agreement style margin margin bottom text indent font size font family time roman breach servier material obligation pursuant this agreement style margin margin bottom text indent font size font family time roman except each case extent such claim result from material breach miragen indemnitee covenant representation warranty other agreement made miragen this agreement gross negligence willful misconduct miragen indemnitee style margin margin bottom text indent font size font family time roman indemnification procedure either party seeking indemnification under section indemnified party shall inform other party indemnifying party claim giving rise obligation indemnify pursuant such section soon reasonably practicable after receiving notice claim indemnifying party shall have right assume defense such claim which obligated indemnify indemnified party which shall include right settle claim nbsp without written consent indemnified party settlement involves only payment money nbsp with prior written consent indemnified party such consent unreasonably withheld other circumstance indemnified party shall cooperate with indemnifying party indemnifying party insurer indemnifying party reasonably request indemnifying party cost expense indemnified party shall have right participate expense with counsel choice defense claim that been assumed indemnifying party neither party shall have obligation indemnify other party connection with settlement made without indemnifying party written consent which consent shall unreasonably withheld delayed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman party agree application section nbsp claim pending resolution dispute pursuant section nbsp party conduct separate defense such claim with each party retaining right claim indemnification from other party accordance with section nbsp upon resolution underlying claim style margin margin bottom text indent font size font family time roman mitigation loss each indemnified party shall take shall procure that affiliate take such reasonable step action reasonably necessary indemnifying party reasonably require order mitigate claim potential loss damage under this article nothing this agreement shall shall deemed relieve party common other duty mitigate loss incurred style margin margin bottom text indent font size font family time roman limitation liability neither party shall liable other special consequential including limited loss profit loss revenue incidental punitive indirect damage arising from relating breach this agreement regardless notice possibility such damage notwithstanding foregoing nothing this section intended shall limit restrict indemnification right obligation party under section damage available party breach confidentiality obligation article this limitation liability apply extent german allow such limitation style margin margin bottom text indent font size font family time roman insurance each party shall procure maintain insurance including product liability insurance with respect activity hereunder which consistent with normal business practice prudent company similarly situated time during which licensed product being clinically tested human subject commercially distributed sold each party shall provide other party with evidence such insurance upon request shall provide other party with written notice least thirty nbsp prior such party decision receipt notice from insurance company applicable with respect cancellation renewal material decrease coverage level such insurance understood that such insurance shall construed create limit either party liability style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center general provision style margin margin bottom text indent font size font family time roman force majeure neither party shall held liable other party deemed have defaulted under breached this agreement failure delay performing obligation under this agreement extent such failure delay caused result from cause beyond reasonable control affected party potentially including embargo whether declared terrorism insurrection riot civil commotion strike lockout other labor disturbance fire flood earthquake other omission delay acting governmental authority other party unavailability material related manufacture licensed oligos licensed product affected party shall notify other party writing such force majeure circumstance soon reasonably practical shall promptly undertake continue diligently reasonable effort necessary cure such force majeure circumstance perform obligation spite ongoing circumstance style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman assignment this agreement assigned otherwise transferred right obligation hereunder assigned transferred either party without prior written consent other party notwithstanding foregoing either party without consent other party assign this agreement right obligation hereunder whole part affiliate such party whole successor interest connection with sale substantially stock asset which this agreement relates connection with merger acquisition similar transaction permitted assignee shall assume shall confirm writing other party that will assume assigned obligation assignor under this agreement provided that assignor nbsp shall released from exclusivity obligation forth section nbsp confidentiality obligation forth article nbsp shall jointly severally liable with permitted assignee breach assigned right obligation attempted assignment accordance with this section nbsp shall null void legal effect term condition this agreement shall binding upon shall inure benefit party their respected successor permitted assigns patent right know owned licensed permitted assignee entity becomes affiliate miragen during term through change control each case existing date closing transaction that basis such assignment resulted such entity becoming affiliate shall automatically excluded from right licensed other party under this agreement except right granted servier under section nbsp event such affiliate permitted assignee miragen acquiror miragen shall promptly notify servier change control style margin margin bottom text indent font size font family time roman subcontracting notwithstanding provision contrary neither party shall entitled subcontract third party enter into agreement with third party performance such third party clinical work related licensed oligo target without having obtained prior approval style margin margin bottom text indent font size font family time roman severability more provision contained this agreement held invalid illegal unenforceable respect validity legality enforceability remaining provision contained herein shall affected impaired thereby unless absence invalidated provision adversely affect substantive right party party shall such instance their best effort replace invalid illegal unenforceable provision with valid legal enforceable provision which insofar practical implement purpose this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman notice notice which required permitted hereunder shall writing sufficient delivered personally sent facsimile promptly confirmed personal delivery registered certified mail overnight courier sent nationally recognized overnight courier sent registered certified mail postage prepaid return receipt requested addressed follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign miragen valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign miragen therapeutic valign bottom nbsp nbsp valign bottom style font family time roman font size valign lookout suite valign bottom nbsp nbsp valign bottom style font family time roman font size valign boulder valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign attn valign bottom nbsp nbsp valign bottom william marshall style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign with copy valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign cooley valign bottom nbsp nbsp valign bottom style font family time roman font size valign hanover street valign bottom nbsp nbsp valign bottom style font family time roman font size valign palo alto valign bottom nbsp nbsp valign bottom style font family time roman font size valign attn valign bottom nbsp nbsp valign bottom marya postner style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign servier valign bottom nbsp nbsp valign bottom style font size height colspan style font family time roman font size valign colspan institut recherches servier publique style font family time roman font size valign suresnes valign bottom nbsp nbsp valign bottom style font family time roman font size valign france valign bottom nbsp nbsp valign bottom style font family time roman font size valign attn valign bottom nbsp nbsp valign bottom head research style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign with copy except invoice valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign laboratoires servier valign bottom nbsp nbsp valign bottom style font family time roman font size valign carnot valign bottom nbsp nbsp valign bottom style font family time roman font size valign suresnes cedex valign bottom nbsp nbsp valign bottom style font family time roman font size valign attn valign bottom nbsp nbsp valign bottom legal department style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style margin margin bottom text indent font size font family time roman such other address party whom notice given have furnished other party writing accordance herewith such notice shall deemed have been given nbsp when delivered personally delivered sent facsimile business delivered sent business then next business nbsp business after dispatch sent nationally recognized overnight courier nbsp fifth nbsp business following date mailing sent mail style margin margin bottom text indent font size font family time roman governing this agreement resolution dispute controversy claim arising relating connection with this agreement performance enforcement breach termination this agreement remedy relating thereto shall governed construed accordance with without reference rule conflict style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman dispute resolution style margin margin bottom text indent font size font family time roman party unable resolve dispute arising connection with party respective right responsibility under this agreement then either party written notice other have such dispute referred their executive officer resolve such dispute good faith negotiation event executive officer able resolve such dispute within thirty nbsp after receipt written notice submitting dispute such executive officer such dispute submitted either party arbitration such arbitration shall governed finally settled under rule arbitration international chamber commerce three arbitrator appointed accordance with said rule arbitration proceeding shall take place english language style margin margin bottom text indent font size font family time roman negotiation conducted party pursuant this article shall deemed shall treated compromise settlement negotiation nothing said disclosed document produced course such negotiation which otherwise independently discoverable shall offered received evidence used impeachment other purpose current future arbitration litigation style margin margin bottom text indent font size font family time roman either party apply arbitrator interim injunctive relief until arbitration award rendered controversy otherwise resolved either party also without waiving remedy under this agreement seek from court having jurisdiction injunctive provisional relief necessary protect right property that party pending arbitration award each party shall bear attorney arbitrator administrative arbitration shall shared equally party unless otherwise decided arbitrator style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement together with exhibit hereto contains entire understanding party with respect collaboration license granted hereunder other express implied agreement understanding negotiation writing commitment either oral written respect collaboration license granted hereunder superseded term this agreement exhibit this agreement incorporated herein reference shall deemed part this agreement this agreement amended term hereof modified only written instrument duly executed authorized representative both party hereto party agree that effective effective date that certain exchange proprietary information nondisclosure agreement between party dated september nbsp amended confidentiality agreement shall superseded this agreement that disclosure made prior effective date pursuant confidentiality agreement shall subject confidentiality provision this agreement party acknowledges that remains force effective date hereof shall continue until termination expiration forth therein style margin margin bottom text indent font size font family time roman heading caption several article section subsection hereof part this agreement merely convenience assist locating reading several article section hereof style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman independent contractor expressly agreed that miragen servier shall independent contractor that relationship between party shall constitute partnership joint venture agency neither miragen servier shall have authority make statement representation commitment kind take action which shall binding other party without prior written consent other party style margin margin bottom text indent font size font family time roman waiver waiver either party hereto right hereunder failure other party perform breach other party shall deemed waiver other right hereunder other breach failure such other party whether similar nature otherwise style margin margin bottom text indent font size font family time roman cumulative remedy unless otherwise provided this agreement remedy referred this agreement intended exclusive each shall cumulative addition other remedy referred this agreement otherwise available under style margin margin bottom text indent font size font family time roman waiver rule construction each party opportunity consult with counsel connection with review drafting negotiation this agreement accordingly rule construction that ambiguity this agreement shall construed against drafting party shall apply style margin margin bottom text indent font size font family time roman business requirement event that notice other action omission required taken party under this agreement that business then such notice other action omission shall deemed required taken next occurring business style margin margin bottom text indent font size font family time roman translation this agreement english language only which language shall controlling respect version hereof other language shall accommodation only shall binding upon party communication notice made given pursuant this agreement dispute proceeding related arising hereunder shall english language there discrepancy between translation this agreement this agreement this agreement shall prevail style margin margin bottom text indent font size font family time roman counterpart this agreement executed more counterpart original signature facsimile file each which shall deemed original which together shall constitute same instrument style margin margin bottom font size font family time roman align center remainder page intentionally left blank style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party intending bound have caused this agreement executed their duly authorized representative effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan miragen therapeutic valign bottom nbsp valign valign bottom nbsp valign colspan laboratoires servier style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp valign style border bottom solid william marshall valign bottom nbsp valign valign bottom nbsp valign valign bottom style border bottom solid nbsp valign style border bottom solid christian bazantay style font family time roman font size valign name valign bottom nbsp valign william marshall valign bottom nbsp valign valign bottom nbsp valign name valign bottom nbsp valign bottom christian bazantay style font family time roman font size valign title valign bottom nbsp valign president valign bottom nbsp valign valign bottom nbsp valign title valign bottom nbsp valign bottom proxy style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign valign bottom style border bottom solid nbsp valign style border bottom solid jean philippe seta style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size name font valign bottom nbsp valign bottom font style font size jean philippe seta font style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size title font valign bottom nbsp valign bottom font style font size proxy font style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign colspan font style font size institut recherches servier font style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size font valign bottom style border bottom solid nbsp valign bottom style border bottom solid font style font size emmanuel canet font style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size name font valign bottom nbsp valign bottom font style font size emmanuel canet font style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size title font valign bottom nbsp valign bottom font style font size president research development font style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size font valign bottom style border bottom solid nbsp valign bottom style border bottom solid font style font size bernard marchand font style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size name font valign bottom nbsp valign bottom font style font size bernard marchand font style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign font style font size title font valign bottom nbsp valign bottom font style font size general director research font table style margin margin bottom font size font family time roman align center small ignature small small small small small small small small icense small small small small ollaboration small small greement small small small small small small between small style margin margin bottom font size font family time roman align center small iragen small small herapeutics small small small small small small small small aboratoires small small ervier small style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman list exhibit style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp existing miragen patent style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp target style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp research plan style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp development plan style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp press release style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp certain term upstream license style margin margin bottom font size font family time roman exhibit nbsp nbsp nbsp nbsp exception miragen representation warranty style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit existing miragen patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid style margin margin bottom font size font family time roman align center publication valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center application filing date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center inventor assignee valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center title style font family time roman font size valign align center style margin margin bottom margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center existing miragen patent licensed miragen under santaris agreement style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman exhibit target style margin margin bottom font size font family time roman each target shall comprised certain mature mirna sequence each identified name accession number provided mirbase sanger http microrna sanger sequence index shtml described below each such mirna sequence shall deemed target style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman target valign bottom nbsp nbsp valign bottom align center style border bottom solid target nbsp mirbase nbsp name valign bottom nbsp nbsp valign bottom align center style border bottom solid mirbase nbsp accession nbsp number style font family time roman font size valign rowspan style margin margin bottom margin left text indent font size font family time roman target valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font size height height colspan height colspan style font family time roman font size valign rowspan style margin margin bottom margin left text indent font size font family time roman target valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center research plan style margin margin bottom font size font family time roman research collaboration style margin margin bottom font size font family time roman servier miragen have developed following research plan outline which includes style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center development plan style margin margin bottom font size font family time roman proposed development plan safety clinical pharmacokinetic study phase each licensed product will forth timeline detail clinical clinical development activity effective date party have agreed upon following sample development plan licensed product that directly selectively modulates target that member microrna target family following sample development plan only includes preclinical development activity will updated jrdc provided agreement style margin margin bottom font size font family time roman servier miragen have established following sample development plan outline which includes style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center press release style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp valign logo valign bottom nbsp nbsp valign logo style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign style margin margin bottom font size font family time roman servier contact style margin margin bottom font size font family time roman communication department style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman laurent sorcelle netgrs valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman miragen contact style margin margin bottom font size font family time roman scout investor relation style margin margin bottom font size font family time roman anna sussman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman anna scoutir table style margin margin bottom font size font family time roman align center servier miragen sign million partnership agreement research development style margin margin bottom font size font family time roman align center commercialization cardiovascular microrna modulators style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign miragen retains japanese commercialization right servier gain right other global market table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign servier fund multi year research development plan various target preclinical clinical development cost through phase compound table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign miragen retains option sponsor phase after completion refund part cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign miragen receive regulatory commercial milestone approximately million double digit royalty product sale market outside japan table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign total deal value approximately billion including development support payment miragen table style margin margin bottom text indent font size font family time roman neuilly seine france boulder colo october nbsp laboratoires servier leading european pharmaceutical company with expertise innovative treatment cardiovascular disease miragen therapeutic preclinical stage biopharmaceutical company focused improving patient life developing innovative microrna mirna based therapeutic cardiovascular muscle disease announced today agreement advancing research development commercialization three cardiovascular target including miragen lead program additional target identified this partnership provides worldwide right excluding japan servier style margin margin bottom text indent font size font family time roman under term agreement miragen will receive million total upfront research support near term milestone payment over next three year well royalty sale based successful outcome collaboration additional clinical commercial milestone well clinical development support successful development three compound would value deal approximately billion miragen servier will collaborate research development effort while servier alone will responsible cost associated with global development style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman regulatory approval commercialization three product candidate worldwide excluding japanese market miragen retains right japan option sponsor phase program event that miragen alone together with partner should seek marketing approval target japan style margin margin bottom text indent font size font family time roman very pleased with this partnership which demonstrates once again ability explore truly innovative treatment patient suffering from cardiovascular disease indeed these disease still represent number cause mortality most world said emmanuel canet head servier style margin margin bottom text indent font size font family time roman more more evidence gathering show that some micrornas only cardiovascular biomarkers they also play significant role pathogenesis various disease from heart failure coronary disease added jean paul vilaine head servier cardiovascular unit style margin margin bottom text indent font size font family time roman agreement with servier only provides validation lead program cardiac disease further underscore potential innovative technology platform deliver compelling drug candidate said william marshall president chief executive officer miragen therapeutic delighted partner with servier whose demonstrated leadership expertise development cardiovascular drug truly impressive combining strength hope translate potential microrna targeting into life changing medicine patient need style margin margin bottom text indent font size font family time roman agreement includes miragen lead program which play important role pathogenesis progression heart failure which play role survival proliferative capacity cardiomyocytes agreement also includes additional cardiovascular microrna modulator identified style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign miragen research demonstrated that therapeutic inhibition improve cardiac function survival rate during heart failure addition chemically synthesized inhibitor have been shown suppress pathological cardiac remodeling model heart failure induced chronic high blood pressure while enhancing cardiac function survival table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign research shown that inhibition stimulate cardiomyogenesis process whereby heart muscle cell formed that inhibition spare cardiomyocytes from death during myocardial infarction resulting heart tissue death improvement cardiac function after heart attack table style margin margin bottom font size font family time roman about micrornas micrornas have emerged important class small encoded genome they control expression gene entire pathway thus thought master regulator gene expression recent study have demonstrated that micrornas associated with many disease process because they single molecular entity that dictate expression fundamental regulatory pathway micrornas represent potential drug target controlling many biologic disease process style margin margin bottom font size font family time roman about servier servier leading independent pharmaceutical company france with sale worldwide reaching billion servier established country with main therapeutic product treating cardiovascular disease diabetes disorder oncology rheumatological disease more than percent servier turnover invested research development servier more than employee worldwide including nearly more information please visit servier style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman about miragen therapeutic miragen therapeutic founded develop innovative microrna based therapeutic cardiovascular muscle disease only recently discovered micrornas short single stranded molecule encoded genome that regulate gene expression play vital role influencing cardiovascular muscle disease cardiovascular disease leading cause death globally represents enormous burden global healthcare system principally funded through venture capital investment miragen combine world recognized leadership cardiovascular medicine with unprecedented house expertise microrna biology chemistry more information please visit miragentherapeutics style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center certain term upstream license style margin margin bottom font size font family time roman align center agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding exclusive sublicenses granted miragen servier pursuant section nbsp this agreement with respect intellectual property licensed miragen pursuant agreement such intellectual property licensed technology miragen license licensed technology completely exclusive because nbsp university north carolina chapel hill retains right licensed technology internal research teaching other educationally related commercial purpose nbsp extent that such licensed technology invention that claimed patent application issued patent that made with funding from united state government united state government retains right such invention specified united state code section code federal regulation part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding obligation party pursuant section nbsp this agreement keep miragen know confidential obligation party pursuant section nbsp this agreement with respect scientific publication right publish know included licensed technology provided that complies with publication review provision forth section nbsp agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding patent prosecution provision forth section nbsp this agreement unless miragen reach agreement miragen assume responsibility filing prosecution maintenance patent application within licensed technology primary right file prosecute maintain such application such right only subject obligation pursuant section nbsp agreement with respect those patent application within licensed technology that miragen have agreed will agreed miragen assume responsibility filing prosecution maintenance thereof miragen will have obligation forth section nbsp agreement with respect such filing prosecution maintenance such obligation take precedence over provision section nbsp this agreement that consistent therewith table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier regarding infringement alleged infringement miragen patent miragen shall have right fulfill obligation pursuant section nbsp agreement promptly provide with written notice alleged infringement patent within licensed technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding patent enforcement provision forth section nbsp this agreement miragen file suit against substantial infringer patent within licensed technology within knowledge thereof entered into good table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign faith negotiation sublicense such patent such infringer such infringement otherwise ceased then nbsp enforce such patent behalf itself miragen nbsp right retain recovery receives from such enforcement after deduction reasonable attorney court cost connection with such enforcement nbsp miragen shall cooperate with with respect such suit including providing access relevant personnel record paper information sample specimen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agreement terminated time when servier hold sublicense licensed technology servier good standing time such termination then obligated accept servier successor miragen under agreement servier consent writing bound applicable term condition agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect existence term this agreement miragen shall have right fulfill obligation pursuant section nbsp agreement provide with redacted copy this agreement modification termination thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect miragen know servier know other know disclosed servier concerning development activity licensed product miragen shall have right fulfill obligation pursuant section nbsp agreement provide with nbsp annual report concerning effort towards achieving first commercial sale licensed product provided that such licensed product also satisfies definition licensed product forth agreement summarizing licensed product data defined agreement nbsp additional information reasonably requested regarding such effort servier shall promptly provide miragen with such additional information available servier reasonably requested miragen purpose facilitating miragen compliance with such obligation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier regarding initiation clinical trial licensed product approval miragen shall have right fulfill obligation pursuant section nbsp agreement make milestone payment account initiation certain such clinical trial certain such approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier included royalty report provided servier pursuant section nbsp this agreement disclosed miragen pursuant section nbsp this agreement miragen shall have right fulfill obligation nbsp pursuant section nbsp agreement provide with quarterly report concerning sale licensed product provided that such licensed product also satisfies definition licensed product forth agreement calculation royalty owed account such sale nbsp permit audit book table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign ledger record accordance with section nbsp agreement servier acknowledges that definition sale mechanism adjusting sale account sale combination product reducing royalty payment account payment made other licensors currency conversion agreement different from corresponding provision this agreement servier agrees provide least five nbsp before miragen deadline submitting royalty report information available servier reasonably requested miragen purpose facilitating miragen compliance with royalty reporting obligation table style margin margin bottom font size font family time roman align center southwestern agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding exclusive sublicenses granted miragen servier pursuant section nbsp this agreement with respect intellectual property licensed miragen pursuant southwestern agreement such intellectual property licensed subject matter miragen license licensed subject matter completely exclusive because nbsp board regent university texas system board retains right licensed subject matter university texas system research teaching other educationally related commercial purpose nbsp board retains right transfer licensed subject matter other profit academic research institution commercial research which research shall exclude research which commercial entity license option resulting intellectual property nbsp miragen license know within licensed subject matter exclusive board except specified nbsp above permitted grant third party defined southwestern agreement license under such know discover research develop make have made offer sale sell import licensed product defined southwestern agreement nbsp extent that such licensed subject matter invention that claimed patent application issued patent that made with funding from united state government united state government retains right such invention specified united state code section code federal regulation part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding obligation party pursuant section nbsp this agreement keep miragen know confidential obligation party pursuant section nbsp this agreement with respect scientific publication board right publish general scientific finding from research related licensed subject matter provided that disclose confidential information miragen that complies with confidentiality obligation miragen pursuant sponsored research agreement between miragen board table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding patent prosecution provision forth section nbsp this agreement unless miragen assumes responsibility filing prosecution maintenance patent application within licensed subject matter board primary right file prosecute maintain such application such right only subject board obligation pursuant section nbsp southwestern agreement with respect those patent application within licensed subject matter which miragen assumes responsibility filing prosecution maintenance table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign thereof miragen will have obligation forth section nbsp southwestern agreement with respect such filing prosecution maintenance such obligation take precedence over provision section nbsp this agreement that consistent therewith table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier regarding infringement alleged infringement miragen patent miragen shall have right fulfill obligation pursuant section nbsp southwestern agreement promptly provide board with written notice alleged infringement patent within licensed subject matter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding patent enforcement provision forth section nbsp this agreement miragen file suit against substantial infringer patent within licensed subject matter within knowledge thereof entered into good faith negotiation sublicense such patent such infringer such infringement otherwise ceased then nbsp board enforce such patent behalf itself miragen nbsp board right retain recovery receives from such enforcement nbsp board right reduce exclusive license granted miragen pursuant southwestern agreement exclusive license with respect such patent grant exclusive transferable sublicensable license under such patent solely such infringer solely with respect infringing product method nbsp miragen shall cooperate with board with respect such suit including providing access relevant personnel record paper information sample specimen board exercise right reduce exclusive license granted miragen pursuant southwestern agreement exclusive license then such reduction shall exception exclusivity servier sublicense with respect thereto miragen hereby agrees that shall decide file suit against substantial infringer without first discussing with servier opportunity bringing such suit table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign southwestern agreement terminated time when servier hold sublicense licensed subject matter such southwestern agreement servier good standing time such termination then board university texas southwestern medical center obligated accept servier successor miragen under such southwestern agreement servier consent writing bound applicable term condition such southwestern agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect existence term this agreement miragen shall have right fulfill obligation pursuant section nbsp southwestern agreement provide board with redacted copy this agreement modification termination thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier regarding initiation clinical trial licensed product approval miragen shall have right fulfill obligation pursuant section nbsp southwestern agreement make milestone payment board account initiation certain such clinical trial certain such approval table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier concerning commercialization plan activity licensed product miragen shall have right fulfill obligation pursuant section nbsp southwestern agreement provide board with annual written progress report concerning miragen servier effort accomplishment during preceding year diligently commercializing licensed subject matter miragen servier commercialization plan upcoming year servier shall promptly provide miragen with information available servier reasonably requested miragen purpose facilitating miragen compliance with such obligation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier included royalty report provided servier pursuant section nbsp this agreement disclosed miragen pursuant section nbsp this agreement miragen shall have right fulfill obligation nbsp pursuant section nbsp southwestern agreement provide board with quarterly report concerning sale licensed product provided that such licensed product also satisfies definition licensed product forth southwestern agreement calculation royalty owed board account such sale nbsp permit audit book ledger record accordance with section nbsp southwestern agreement servier acknowledges that definition sale mechanism adjusting sale account sale combination product reducing royalty payment account royalty payment made other licensors currency conversion southwestern agreement different from corresponding provision this agreement servier agrees provide least five nbsp before miragen deadline submitting royalty report board information available servier reasonably requested miragen purpose facilitating miragen compliance with royalty reporting obligation board table style margin margin bottom font size font family time roman align center santaris agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license granted miragen servier pursuant section nbsp this agreement servier acknowledges that know within platform technology defined santaris agreement that pertains table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license granted miragen servier pursuant section nbsp this agreement with respect intellectual property licensed miragen pursuant santaris agreement santaris sublicenses license granted miragen pursuant section nbsp santaris agreement product license limited scope such product license product license limited research other than discover development manufacture commercialization such term defined santaris agreement product treatment prevention mitigation disease disorder medical condition human wherein term product mean pharmaceutical product that contains least single stranded oligonucleotide that nbsp contains least methylene ribonucleoside that claimed santaris table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign patent nbsp such term defined section nbsp santaris agreement nbsp nbsp designed being developed exert biological effect through binding such miragen target clarity effective date term miragen target limited mature microrna sequence identified schedule santaris agreement that within microrna target family microrna target family target family therefore unless third target replacement target accepted santaris inclusion under santaris agreement pursuant paragraph amendment license agreement between santaris miragen dated october nbsp santaris amendment which case party will amend this exhibit accordingly target family chosen target pursuant section nbsp this agreement servier license pursuant section nbsp this agreement include sublicense santaris with respect licensed product that contains licensed oligo that modulates third target replacement target such license shall cease include licensed product that contain licensed oligos that modulate microrna target family microrna target family replacement target selected such target family accordance with section nbsp this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license granted miragen servier pursuant section nbsp this agreement because table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miragen grant sublicense servier under product license servier grant subsequent sublicense thereof contingent upon such sublicense being writing being subject subordinate consistent with term santaris agreement that apply such sublicense which term condition forth this exhibit servier hereby agrees comply with agrees cause sublicensees comply with those term santaris agreement forth this exhibit including following term santaris agreement nbsp keeping book record with respect sale product period year after year which they were generated nbsp permitting santaris pharma santaris audit through independent auditor consistent with section nbsp santaris agreement such book record sole purpose verifying sale based payment defined section nbsp santaris agreement made miragen pursuant section nbsp santaris agreement nbsp indemnifying santaris from against liability loss damage expense cost that santaris affiliate defined santaris agreement licensors assignor each their respective employee officer director agent collectively santaris indemnitees incurs suffers resulting from arising third party claim arising servier sublicensee applicable development manufacture commercialization product single stranded oligonucleotide described above being contained therein including patent infringement personal injury death person result such product oligonucleotide except extent caused nbsp gross negligence willful misconduct santaris santaris indemnitee nbsp santaris representation forth santaris agreement being untrue when made nbsp breach santaris covenant under santaris agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miragen servier long servier sublicense under santaris pursuant this agreement servier sublicensees santaris shall until earliest nbsp nbsp nbsp party shall agree upon development plan that allows miragen servier comply with such obligation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miragen servier servier sublicensees santaris shall human material defined santaris agreement procured miragen pursuant section nbsp santaris agreement servier hereby acknowledges that such material experimental nature shall secure equivalent acknowledgement from sublicensees party shall agree upon development plan that allows miragen servier comply with such obligation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect miragen know servier know other know disclosed servier concerning development activity plan licensed product miragen shall have right fulfill obligation pursuant nbsp section nbsp santaris agreement provide defined santaris agreement with report concerning miragen research activity with respect each target family defined santaris agreement which research license terminated including summary data result with respect such target family assessment likelihood timetable completion impd enabling study filing such target family nbsp section nbsp santaris agreement provide semi annual report regarding product research development activity meet with santaris upon santaris request review such product research development activity servier shall promptly provide miragen with information available servier reasonably requested miragen purpose facilitating miragen compliance with such obligation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect existence term this agreement miragen shall have right fulfill obligation pursuant section nbsp santaris agreement provide santaris with quarterly report concerning consideration received miragen from servier account miragen grant sublicense santaris provided that such consideration also satisfies definition sublicense revenue forth santaris agreement calculation payment owed santaris account such consideration table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier included royalty report provided servier pursuant section nbsp this agreement disclosed miragen pursuant section nbsp this agreement miragen shall have right fulfill obligation pursuant section nbsp santaris agreement provide santaris with quarterly report concerning sale licensed product provided that such licensed product also satisfies definition product forth santaris agreement calculation royalty owed santaris account such sale servier acknowledges that definition sale mechanism adjusting sale account sale combination product reducing royalty payment account lack valid claim defined santaris agreement within santaris that claim table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign composition matter method using such licensed product country sale reducing royalty payment account sale generic version such licensed product currency conversion santaris agreement different from corresponding provision this agreement servier agrees provide least five nbsp before miragen deadline submitting royalty report santaris information available servier reasonably requested miragen purpose facilitating miragen compliance with royalty reporting obligation santaris table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect miragen know servier know other invention disclosed servier pursuant section nbsp this agreement miragen shall have right fulfill obligation pursuant section nbsp santaris agreement disclose santaris improvement platform technology defined santaris agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign servier hereby grant santaris worldwide exclusive irrevocable fully paid license with right sublicense exploit purpose improvement platform technology made servier affiliate servier affiliate shall take appropriate step ensure that their employee consultant other personnel obligated grant such license santaris table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding patent prosecution provision forth section nbsp this agreement santaris sole right prepare file prosecute maintain patent within santaris technology defined santaris agreement such right only subject santaris obligation pursuant section nbsp santaris agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding miragen confidentiality obligation pursuant article with respect confidential information servier regarding infringement alleged infringement miragen patent miragen shall have right fulfill obligation pursuant section nbsp santaris agreement promptly provide santaris with written notice alleged infringement miragen patent defined santaris agreement patent within santaris table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding patent enforcement provision forth section nbsp this agreement santaris sole right enforce patent within platform technology defined santaris agreement first right enforce patent within santaris technology defined santaris agreement provided that third party infringes patent within platform technology santaris technology selling product comprising miragen compound field then santaris shall nbsp enforce such patent within platform technology santaris technology against such third party santaris sole cost expense nbsp permit miragen enforce such patent within santaris technology patent within platform technology miragen cost expense provided section nbsp santaris agreement santaris enforces such patent miragen shall assist cooperate with santaris with respect such suit santaris right retain after reimbursement santaris miragen expense incurred connection with such enforcement action recovery receives from such table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign enforcement miragen enforces such patent nbsp santaris participate expense with counsel proceeding relating validity such patent nbsp miragen obligated keep santaris reasonably informed material development relating such enforcement action nbsp santaris shall bound offer settlement compromise without prior written consent which shall unreasonably withheld nbsp miragen obligated santaris after reimbursement santaris miragen expense incurred connection with such enforcement action recovery receives from such enforcement except extent that such payment would otherwise table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center exception miragen representation warranty style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp body html text document